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Abstract 
A study of the relationship between C-type natriuretic peptide and 
pregnancy in sheep and red deer 
 
by 
Bryony Alice McNeill 
 
C-type natriuretic peptide (CNP) is a signaling molecule with important roles in mammalian 
growth and vascular function. Unexpectedly high plasma CNP concentrations have been 
reported in late gestation ewes, suggesting a possible role during pregnancy. However, the 
temporal pattern of CNP in maternal circulation, site/s of production and function during 
pregnancy have not been identified. Consequently, the aim of this PhD project was to address 
these unexplored aspects of CNP biology in order to improve our understanding of CNP’s 
role in pregnancy. 
 
To characterise the temporal pattern of maternal circulating CNP during pregnancy, a 
longitudinal survey was conducted in two representative species of ruminant: sheep and red 
deer. Plasma concentrations of both CNP and a presumed bio-inactive fragment of its 
precursor (NTproCNP) increased in twin-bearing ewes at 40-50 days of gestation with peak 
values attained (CNP 31 ± 5 pmol l-1, NTproCNP 270 ± 16 pmol l-1) at about day 120. A 
similar temporal pattern was evident in red deer hinds. In pregnant ewes studied at day 120, 
there was a positive relationship between maternal CNP forms and fetal number (P < 0.01). 
Collectively, these results strongly implicated the uteroplacental unit as the major source of 
CNP during pregnancy. Therefore, studies were conducted to determine the relative 
contribution of uterine and placental tissues to circulating CNP concentration. The 
concentration of both CNP forms in the placenta exceeded that in intercaruncular uterine 
tissue throughout pregnancy (P < 0.05), with the highest concentrations measured in the fetal 
cotyledon. Immunohistochemistry revealed staining of CNP and NTproCNP around placental 
blood vessels and in trophoblast binucleate cells (BNC), identifying these cells as a probable 
source of maternal circulating CNP during pregnancy.  
 
 iii
Having identified the source of CNP during pregnancy, further studies were undertaken to test 
the hypothesis that CNP production by the ovine uteroplacental unit is homeostatically 
regulated by nutritional status, using models of nutrient restriction (3-day fast) or nutrient 
abundance (caloric loading or mid-pregnancy shearing). Maternal circulating NTproCNP 
concentration, expressed as a percentage of  pre-fasting concentration, was significantly 
elevated in ewes fasted in late pregnancy compared with controls (117 ± 5.1 % vs 107 ± 3.5 
%, P < 0.05). In contrast, there was no effect of nutrient abundance on the concentration of 
either CNP form, suggesting that CNP production is selectively upregulated during situations 
of  fetal restriction. 
 
CNP’s localisation to the BNC and high circulating concentrations in the pregnant ruminant 
suggest a novel endocrine role for the peptide during pregnancy, in addition to likely 
paracrine actions within the placental vasculature. The strong relationship between maternal 
circulating CNP and placental peptide production identified in this thesis makes the pregnant 
ewe a unique in vivo model for studying the regulation of CNP during pregnancy, and may 
reveal potential applications for this peptide as a marker of maternal and/or fetal health and 
wellbeing in both human medicine and animal production. 
 
Keywords: C-type natriuretic peptide, CNP, NTproCNP, placenta, fetus, pregnancy, sheep, 
red deer, binucleate cell, caloric restriction, caloric loading, mid-pregnancy shearing 
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    Chapter 1: 
General introduction 
C-type natriuretic peptide (CNP) is one of a number of structurally-related peptides belonging 
to the natriuretic peptide family. In contrast to the other natriuretic peptides, which are 
involved in salt and water homeostasis and cardiac health, the primary roles of CNP are 
believed to relate to vascular function and skeletal growth. A role in reproduction has also 
been proposed (reviewed by Walther & Stepan, 2004), as CNP and its receptor have been 
identified in a number of reproductive tissues in both male and female mammals, including 
the ovary, uterus, and testes. 
 
In 2007, Prickett et al. reported unusually high plasma concentrations of CNP and the 
presumed bioinactive amino-terminal fragment released during processing of proCNP 
(NTproCNP) in late-gestation ewes, suggesting a possible role for CNP in pregnancy. The 
findings of this study also raised the hypothesis that CNP production during pregnancy may 
be homeostatically regulated by nutrition. However, nothing was known of CNP’s 
involvement (if any) during early- and mid-pregnancy, or how these findings related to CNP 
activity during pregnancy in other ruminant species. Furthermore, the cellular site/s of CNP 
production and the factors controlling its regulation during pregnancy had not been 
determined. Consequently, this PhD project was initiated to address some of the important 
questions raised by the findings of Prickett et al. (2007), with the intention of furthering our 
understanding of the biology of CNP during pregnancy.  
 
The primary aim of this research project was to document the temporal pattern of CNP and 
NTproCNP in maternal circulation for the duration of pregnancy to determine the stage of 
pregnancy at which the increase in CNP occurred and relate this to important physiological 
events of pregnancy. In addition to studies in sheep, red deer were included to determine 
whether the previous findings in pregnant ewes are a common feature of ruminant pregnancy, 
or whether they may be unique to the ovine situation. The results of this longitudinal survey 
are presented in Chapter 4. Having characterised the pattern of CNP forms in maternal 
circulation throughout pregnancy, subsequent experiments were conducted to identify the 
source of CNP during pregnancy (Chapter 5) and to test the hypothesis that CNP production 
is homeostatically regulated by nutrition (Chapters 6 and 7), with an ultimate goal of 
understanding the role of this hormone during pregnancy. The major findings and important 
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contributions of these studies, as well as key areas remaining to be addressed are discussed in 
Chapter 8, with reference to the potential applications of this work both for human medicine 
and animal production.  
 3
    Chapter 2: 
Literature review 
 
2.1 Introduction to the natriuretic peptides 
2.1.1 ANP and BNP 
In mammals, the natriuretic peptide (NP) family consists of at least three structurally-related 
peptides; atrial (ANP), B-type (BNP) and C-type (CNP) natriuretic peptide, although other 
NPs have been identified in lower vertebrates (Kawakoshi et al., 2004). ANP and BNP are 
produced in the atrium and ventricle respectively, and their secretion is stimulated by atrial or 
ventricular wall stretch. These peptides act in an endocrine fashion to regulate blood pressure 
and volume homeostasis by promoting vasodilation, increasing fluid and electrolyte excretion 
(natriuresis) and inhibiting renin and aldosterone secretion (reviewed by Tremblay et al., 
2002). The natriuretic effects of ANP were first discovered when rats displayed a reduction in 
blood pressure and an increase in both urine quantity and electrolyte concentration after being 
given extracts of atrial myocardium (de Bold et al., 1981). In health, circulating 
concentrations of ANP exceed those of BNP and CNP. A notable exception is in cases of 
congestive heart failure, in which circulating BNP concentrations increase dramatically. The 
biology of ANP and BNP has been described previously in numerous reviews (for example, 
Tremblay et al., 2002; Potter et al., 2006; Woodard & Rosado, 2008). 
 
2.1.2 CNP 
CNP was first identified following isolation from the porcine brain (Sudoh et al., 1990) and, 
in mammals, is detectable in two forms; CNP-22 and CNP-53 (Figure 2-1). CNP-22 is the 
predominant form in the circulation whereas CNP-53 is more prevalent in tissues (Stingo et 
al., 1992). Functionally, CNP is distinct from the other members of the NP family. For 
example, despite its name CNP does not stimulate natriuresis when administered to achieve 
physiological concentrations (Hunt et al., 1994) and, unlike BNP, circulating CNP 
concentration is not elevated in congestive heart failure (Kalra et al., 2001). Similarly, CNP’s 
hypotensive effects are also smaller than those of the other natriuretic peptides (Sudoh et al., 
1990). Also, CNP’s mode of action is unique within the NP family; acting primarily in a 
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paracrine/autocrine fashion in contrast to the classical endocrine actions of ANP and BNP 
(Scotland et al., 2005). 
 
All three NPs share a common 17 amino acid ring structure and amino-terminal ‘tail’ of 
varying length (Figure 2-1). The gene for CNP is located on a different chromosome from 
those of other NPs (Komatsu et al., 2002) and is likely to be the ancestral molecule from 
which ANP and BNP are derived (Inoue et al., 2003).  
 
 
  
Figure 2-1. Structure of huma n ANP, BNP a nd CNP. 
The mature form of human ANP, BNP and CNP. Shaded amino acids are conserved among the 
three NPs. Figure reproduced from Yandle (1994) with permission from John Wiley and Sons. 
 
2.1.3 Natriuretic peptide receptors 
The biological effects of the NPs are achieved via interaction with the guanylyl cyclase 
receptors NPR-A or NPR-B and synthesis of the intracellular signalling molecule cyclic 
guanosine monophosphate (cGMP) (reviewed by Tremblay et al., 2002). Binding of the 
natriuretic peptides to the extracellular binding domain of these transmembrane receptors 
results in activation of the particulate form of guanylyl cyclase, an enzyme involved in 
catalysing the production of cGMP (Tremblay et al., 2002). In contrast to ANP and BNP, 
which interact with the NPR-A receptor, CNP binds preferentially to NPR-B, which is known 
also as ANP-B (Suga et al., 1992), GC-B or NPR2 (Agoston et al., 2006) receptor. To 
minimise confusion, the term NPR-B will be used throughout this review. The gene for this 
receptor, NPR2, has been identified in brain, pituitary gland, adrenal gland, kidney, lung, 
cartilage and various reproductive tissues (Olney et al., 2006).  
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Also, another receptor known as the NPR-C functions to process circulating CNP (Madhani et 
al., 2003), and is the most abundant NP receptor form (Scotland et al., 2005). The 
physiological actions of NPR-C are achieved by inhibition of adenylyl cyclase activity and 
cAMP generation (reviewed by Anand-Srivastava, 2005). Also, NPR-C functions as a 
clearance receptor; modulating the bioavailability of the NPs (Scotland et al., 2005). The 
structure of the three receptors is illustrated in Figure 2-2. 
 
 
 
Figure 2-2. Sc hematic dia gram of the three natriuretic pe ptide receptors  
Schematic diagram of the three natriuretic peptide receptors. From top to bottom: NPR-A, NR-
B and NPR-C. The order of selectivity for the three receptor forms is shown to the right of the 
figure. Reproduced from Yandle (1994) with permission from John Wiley and Sons. 
 
As well as interaction with NP receptors, CNP can also be processed by the enzyme neutral 
endopeptidase, a zinc metalloprotease (Walther et al., 2004). This enzyme aids in the 
hydrolysis of internal peptide bonds in CNP, thus opening up the ring structure (Walther et 
al., 2004). Neutral endopeptidase has been identified in a range of tissues including heart, 
kidney, lung and endothelium (reviewed by Scotland et al., 2005).  
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2.1.4 N-terminal fragments 
ANP, BNP and CNP are synthesised initially as preprohormones (Potter et al., 2006), which 
are then processed intracellularly to form a biologically-active mature peptide as well as a 
biologically-inactive amino-terminal portion, known as NTproANP, NTproBNP and 
NTproCNP, respectively. These amino-terminal fragments circulate at much higher 
concentrations than the active peptide forms as they are not degraded by neutral 
endopeptidase or cleared from the circulation by NPR-C (Charles et al., 2006). The extremely 
short half-life of CNP (2-4 minutes in sheep) has presented difficulties for measuring 
circulating concentrations of the peptide in blood samples (Prickett et al., 2001). However, the 
extended half -life of NTproCNP provides an alternative and possibly more reliable measure 
of CNP activity in vivo (Prickett et al., 2001). 
2.1.5 The role of CNP 
In contrast to ANP and BNP, with established roles in salt and water homeostasis, the 
functions of CNP are diverse, and have not been characterised to the same extent as the other 
NPs. To date, most research has focussed on CNP’s activity within the vasculature, neural 
tissue, in the growing skeleton and in reproductive tissues. 
 
2.1.5.1 CNP in the vasculature 
CNP and NPR-B mRNA and protein have been identified in vascular smooth muscle cells 
(VSMCs) (Suga et al., 1992; Woodard et al., 2002), comprising the ‘vascular natriuretic 
peptide system’ (Suga et al., 1993); a local NP system which involves paracrine/autocrine 
induction of vasodilation and growth inhibition of VSMCs by CNP (Suga et al., 1993). The 
vasodilatory effects of CNP are achieved either by interaction with the NPR-B receptor, 
resulting in accumulation of cGMP (Furuya et al., 1991) and relaxation of the vascular wall 
(Itoh et al., 1998) or through interaction with NPR-C and activation of G protein-gated 
inwardly rectifying K+ channel (Chauhan et al., 2003).The vasodilatory actions of CNP are 
more potent in venous compared with arterial vessels (Wei et al., 1993). 
 
Endothelial shear stress, when present at high levels, is a potent stimulator of CNP secretion 
in the vasculature (Okahara et al., 1995; Chun et al., 1997). Shear stress acts on the surface of 
blood vessels; in the direction of blood flow (Okahara et al., 1995), and is detected by 
mechanoreceptors on cells of the vascular endothelium (Okahara et al., 1995). In addition to 
regulating vascular tone and VSMC growth, CNP is likely also to be involved in angiogenesis 
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(Yamahara et al., 2003). CNP’s role in vascular health and disease has been reviewed 
previously (Ahluwalia & Hobbs, 2005; Scotland et al., 2005). 
 
2.1.5.2 CNP in nervous tissue 
Very high concentrations of CNP and NPR-B have been identified in brain, spinal cord and 
cerebrospinal fluid (Togashi et al., 1992; Potter et al., 2006). The role of CNP within the 
nervous system has not been conclusively determined, but possible roles include regulating 
the synthesis and/or secretion of neuroendocrine hormones (Samson et al., 1993) and 
neuronal development (DiCicco-Bloom et al., 2004; Müller et al., 2009). 
 
2.1.5.3 CNP in skeletal tissue 
In recent years, there has been significant interest in the importance of CNP in mammalian 
growth, particularly skeletal growth. The development of CNP knock-out mouse models, with 
impaired skeletal growth and pronounced dwarf phenotype, has been a strong driver of this 
research. Specifically, CNP plays a critical role in endochondral ossification; the process by 
which cartilaginous tissue becomes calcified and replaced by bone (Bartels et al., 2004). In 
humans, a naturally-occurring mutation in the NPPC gene which codes for the NPR-B 
receptor has been identified in individuals with acromesomelic dysplasia: type Maroteaux, an 
autosomal recessive condition associated with a dwarf phenotype due to inappropriately 
formed growth plates (Bartels et al., 2004). Conversely, overexpression of NPPC in humans 
results in marked skeletal overgrowth due to inappropriately high CNP production (Bocciardi 
et al., 2007; Moncla et al., 2007). The putative role of CNP in skeletal growth and 
development has been described in detail in published reviews (Komatsu et al., 2002; Espiner 
et al., 2007; Teixeira et al., 2008).  
 
2.1.5.4 CNP and the reproductive system 
Elevated CNP gene expression has been identified in various reproductive tissues in both 
males and females in a number of mammalian species, indicating that a functional role for 
CNP in mammalian reproduction is likely. Modulation of CNP gene expression by oestradiol 
in the uterus (Acuff et al., 1997; Jankowski et al., 1997) and by luteinising hormone and 
gonadotrophin releasing hormone within the anterior pituitary gland (McArdle et al., 1993; 
McArdle et al., 1994), suggest that the circulating concentration and local production of the 
peptide may be regulated by reproductive hormones. A description of CNP mRNA expression 
and possible function in mammalian reproduction has been reviewed in detail by Walther and 
Stepan (2004).  
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2.1.5.5 CNP and fetal development 
There is a relative paucity of data regarding the development of CNP signalling in the fetus, 
with the data published prior to 2004 summarised in a review by Walther and Stepan (2004). 
CNP signalling in the fetus appears to be functional by mid- to late-gestation with significant 
concentrations of CNP being detected in the circulation of fetal sheep (Prickett et al., 2007) 
and humans (Stepan et al., 2000), which is likely to be regulated independently from the 
maternal system (Prickett et al., 2007).  
 
The role of CNP in fetal development has not been determined conclusively. As discussed by 
Prickett et al. (2007), the skeletal effects of disrupted CNP signalling in gene knock-out 
models are generally not evident at birth, and in neonatal mice (12 hours post-delivery) CNP 
mRNA expression is strong in the brain but completely absent from the femur (Stepan et al., 
2000), indicating that CNP is unlikely to play an important role in fetal skeletal growth. 
Alternatively, CNP may have an important role in development of the fetal brain and 
peripheral nervous system. Expression of CNP and NPR-B mRNA is abundant in the 
embryonic mouse and rat brain (Cameron et al., 1996; Müller et al., 2009), and abnormalities 
in sensory neuron function have been reported in CNP knock-out mice. Furthermore, 
mitogenic effects of CNP on dorsal root ganglia (DiCicco-Bloom et al., 2004) and strong 
temporal similarities in the expression of NPR-B and nestin, a marker of neural progenitor 
cell activity, indicate a possible role for CNP in neurogenesis (Müller et al., 2009). 
2.2 Pregnancy and placentation 
Evolution of the eutherian (placental) mode of reproduction conferred significant evolutionary 
advantages, and has consequently become a highly successful reproductive strategy. In 
placental mammals, the developing embryo is physically contained and nourished by the 
pregnant female, providing protection from adverse conditions including dehydration, 
flooding, predation and temperature extremes (Blackburn, 1999). Pregnancy requires a 
coordinated communication between mother and fetus and is a time of many physiological 
changes. As the current study relates to CNP’s role in ovine and cervine pregnancy, and 
because this may have implications for the human event, this review will focus on discussion 
of pregnancy in these species. 
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2.2.1 The placenta 
The eutherian placenta is formed by the establishment of a connection between the 
extraembryonic membranes and the uterine epithelium (Senger, 2005) thus providing an 
effective means of nourishment for the developing fetus. Placentation in ruminants is 
characterised by the development of placentomes; discreet units where fetal placental tissue 
(cotyledon) attaches to caruncular regions on the maternal uterus to establish a point of 
contact between the developing conceptus and its dam, thus forming a placenta.  
 
The number of placentomes in a pregnancy varies among ruminant species; ranging from 4-6 
large placentomes in red deer (Wooding et al., 2007) up to 100 in a normal ovine placenta 
(Ward et al., 2006). Placentomes can be categorised as A-, B-, C- or D-type, depending on 
their morphology and proportion of maternal and fetal tissue (Vatnick et al., 1991). The 
majority of pregnancy is dominated by A- and B-type placentomes, with a greater proportion 
of C- and D-type placentomes appearing only late in gestation (Ward et al., 2006). A higher 
proportion of C- and D-type placentomes are also present with larger litter sizes and in cases 
of suboptimal intrauterine conditions in early pregnancy (Ward et al., 2006). These 
placentomes are larger and believed to be more efficient than A- and B-types, and their 
increased abundance in compromised pregnancies may be an adaptive response to cope with 
reduced nutrient availability (Vonnahme et al., 2006; Ward et al., 2006).   
 
The ruminant placenta was originally classified as syndesmochorial, as early studies reported 
partial destruction of the maternal uterine epithelium and direct contact between the 
trophectoderm and maternal connective tissue (reviewed by Wooding, 1992). However, an 
intact uterine epithelium has since been identified and the classification modified to 
epitheliochorial (Wooding, 1982). This type of placenta is characterised by a direct contact 
between the uterine epithelium and chorion with no destruction of the uterine epithelium 
(Wooding, 1992). Although this second classification may be more fitting, Wooding (1992) 
argues that, as the uterine epithelium is highly modified to form a fetal-maternal hybrid tissue, 
neither of these placental classifications is entirely appropriate for describing the placenta of 
ruminants. 
 
In contrast, the human placenta is classified as haemochorial (Senger, 2005). This type of 
placenta is associated with invasive, or interstitial, implantation in which the conceptus 
becomes completely imbedded in the maternal endometrial tissue to become physically 
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separated from the luminal space (Senger, 2005). The deep invasion of maternal tissue by the 
human conceptus results in the establishment of a direct contact between the terminal villi of 
the chorionic syncytiotrophoblast and maternal blood (Johnson, 2007). In the non-invasive 
ruminant placenta, the conceptus remains in the uterine luminal compartment for the duration 
of pregnancy, also known as eccentric implantation (Johnson, 2007). 
 
2.2.2  Trophoblast binucleate cells 
A unique feature of ruminant pregnancy is the presence of trophoblast binucleate cells (BNC). 
These cells first appear at implantation (Wango et al., 1990), making up approximately 20 % 
of fetal trophoblast cells and persist until the final week of pregnancy when their abundance 
sharply declines to around 8 % (Wooding, 1982). BNC are present in all species of ruminant 
examined thus far, including the mouse deer which belongs to the most primitive group of 
ruminant, the tragulidae (Wooding et al., 2007). BNC provide a method of hormone delivery 
which allows transport of products from fetus to mother without activation of a maternal 
immune response. The formation, migration and control of BNC activity has been reviewed 
previously (Wooding, 1982; Lee et al., 1995; Wooding et al., 2007).  
 
2.2.3 Relevance of animal models to human pregnancy 
Due to the high risks and ethical constraints of studying human pregnancy, much of our 
knowledge regarding fetal and placental physiology has been gained from animal studies 
(Handwerger et al., 1975). In particular, the pregnant ewe is one of the most widely studied 
models of pregnancy and parturition. There are considerable advantages of this model for the 
study of human pregnancy: the ewe has a long gestation period, is easy and inexpensive to 
house and both the ewe and her neonate are of comparable body weight to humans. The small 
litter size and relative maturity of the neonatal lamb may also provide a more relevant model 
than rodent species. Furthermore, the large size of the ewe and developing fetus allow for the 
easy collection of blood and tissue samples in sizable volumes, and allow for serial 
measurements. 
 
However, despite the many similarities between ovine and human pregnancies there are some 
important differences between the two species. Sheep models have been used widely for the 
study of high-risk pregnancies, such as intrauterine growth retardation (IUGR) and 
preeclampsia. However, true preeclampsia occurs only in humans and apes, and the various 
ovine models designed to replicate this condition may involve different mechanisms to those 
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present in humans (Podjarny et al., 1999). The placental structure and manner of implantation 
also show considerable variation between the two species (Barry & Anthony, 2008), and there 
are endocrine differences between the two species in normal pregnancy (Johnson, 2007). 
Consequently, although the sheep is an extremely useful tool in the study of human 
pregnancy, information gained from such animal models must be applied to the human 
situation with some caution. 
2.3 Involvement of CNP in pregnancy 
The function/s (if any) of CNP during mammalian pregnancy have only recently come under 
investigation, with results to date sometimes being inconclusive and often contradictory. 
However, a sufficient number of studies implicate a role for the peptide in pregnancy, and 
support the need for further research in this field. The remainder of this review will examine 
evidence for an involvement of CNP in pregnancy using the literature available at the 
commencement of this PhD programme.  
 
In 1998 Itoh et al. reported a decrease in NP clearance receptor abundance in the uterine 
arteries of pregnant ewes (Itoh et al., 1998). Together with the finding that the concentration 
of cGMP is significantly upregulated in plasma and urine during pregnancy (reviewed by Itoh 
et al., 1999), these data may be indicative of an increase in CNP activity or synthesis in the 
pregnant female (Itoh et al., 1998). Surprisingly however, when circulating CNP 
concentration was measured in pregnant women, no elevation was found compared with non-
pregnant values (Stepan et al., 1998). In contrast, a more recent study by Prickett et al. (2007) 
reported plasma CNP concentrations to be some 50 times higher in pregnant compared with 
non-pregnant ewes in late gestation, strongly supporting a role for CNP in ovine pregnancy.  
 
Although the source of maternal circulating CNP during pregnancy has not been confirmed, 
there is evidence to suggest that the placenta may be a major contributor. Studies of CNP 
mRNA expression have revealed particularly high gene expression in murine (Cameron et al., 
1996) and human (Stepan et al., 2001) placental tissue. Furthermore, maternal circulating 
NTproCNP concentration is directly related to placental weight in the pregnant ewe (Prickett 
et al., 2007). Higher circulating CNP concentrations in twin- compared with single-bearing 
ewes is also consistent with a placental source, as total placental mass increases with fetal 
number (Prickett et al., 2007).  
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The potent vasoactive properties of CNP and abundant gene expression around the blood 
vessels of the decidua basalis of the placenta suggest that the peptide may have an 
involvement in regulating blood flow and mediating the massive enlargement of blood vessels 
which occurs during pregnancy (Cameron et al., 1996). In women with preeclampsia, 
circulating NTproCNP concentration is significantly elevated (Prickett et al., 2004). In 
preeclampsia, vascular invasion of the uterus is insufficient, resulting in decreased blood flow 
to the placenta (DiFederico et al., 1999), and elevated CNP secretion in these pregnancies 
may be an adaptive response to the impaired placental development and vascular pathology 
characteristic of the condition. Similarly, IUGR is another condition characterised by 
pathology of the placenta and inappropriate blood flow to the pregnant uterus, and, like 
preeclampsia, is associated with abnormal CNP expression in the uterus and placenta (Stepan 
et al., 2002a). 
 
In women with IUGR, maternal circulating CNP concentration was found not to differ from 
concentrations measured in normal pregnancies (Stepan et al., 2002a). However, it must be 
noted that the elevation in plasma peptide concentration in women with preeclampsia reported 
by Prickett et al. (2004) was evident only in the case of NTproCNP, and not for CNP itself. 
Likewise, an earlier study by Stepan et al. (2002b) found no relationship between circulating 
maternal CNP concentrations and preeclampsia. Thus it is evident that NTproCNP 
concentration may be a more informative measurement of CNP’s activity in vivo, and 
highlights the need for further studies characterising the activity of both CNP and NTproCNP 
in the placenta and maternal circulation in both normal and pathological pregnancies to reveal 
the full extent of CNP’s involvement in pregnancy. 
2.4 Rationale for thesis 
The finding of extremely high circulating concentrations of CNP and NTproCNP in  the 
pregnant ewe (Prickett et al., 2007) suggests an important role in ovine pregnancy, and may 
reflect an entirely new function for this peptide. This finding, together with previous studies 
also raises a number of questions regarding CNP’s regulation, relationship with health and 
disease status, and possible species-related differences. The very high plasma concentrations 
of CNP in ovine pregnancy has also challenged the conventional understanding of CNP’s 
mode of action; strongly suggesting an endocrine role during pregnancy instead of, or in 
addition to, its established role as a paracrine/autocrine factor.  
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In keeping with the principles of comparative physiology, the pregnant ewe appears to be a 
unique model for the study of CNP biology, as it is the only situation identified to date in 
which CNP levels are significantly elevated in the healthy adult. This has implications for 
human health; for example, the elevated circulating oestradiol concentrations during 
pregnancy provide the opportunity to investigate CNP activity during periods of elevated 
steroid hormone concentration; potentially informative in assessing the possible effects of 
CNP on the cardiovascular and other systems during hormone-replacement therapy, for 
example in post-menopausal women (Acuff et al., 1997).  
 
During pregnancy, CNP has potential to be utilised as a marker of fetal and/or maternal 
health. The strong evidence suggesting a placental source for the peptide during pregnancy, 
and changes in CNP gene expression and plasma levels in pathological pregnancies open up 
the possibility that CNP may serve as a new diagnostic tool in indentifying pregnancies at risk 
of IUGR, preeclampsia or other conditions characterised by inappropriate placental function. 
Due to the biological importance and these potential practical applications, there is now a 
critical requirement for further research extending the findings of previous studies to clarify 
the source, maternal concentration and functional role of CNP during pregnancy. 
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    Chapter 3: 
General methods 
This chapter outlines the field and laboratory procedures used throughout the studies 
described in this thesis. Any deviations from these methods are described in the methods 
section of individual experimental chapters. 
3.1 Animal procedures 
3.1.1 Collection of blood samples 
Ewes were placed in groups of around 10 animals in outdoor yards and manually restrained 
for blood sampling, except for the study described in Chapter 6 in which ewes were restrained 
in individual indoor pens. Hinds were placed in groups of 4-6 in an indoor pen and manually 
restrained for blood sampling.  
 
Blood collection from ewes and hinds was by jugular venipuncture into 10 ml evacuated 
blood tubes containing potassium ethylenediaminetetraacetate (EDTA) (natriuretic peptides, 
progesterone, oestradiol and -hydroxybutyrate (-OHB)) or sodium heparinate (insulin-like 
growth factor-1 (IGF-1), glucose and urea) as anticoagulant (Vacutainer, Franklin Lakes NJ, 
USA). Blood tubes were inverted several times to ensure complete mixing of the 
anticoagulant and then immediately placed on ice. Tubes were centrifuged at 800 g for 10 
minutes at 4 °C, then plasma was transferred into polystyrene tubes and stored at -20 °C until 
required. Plasma was aliquotted into separate tubes for each analyte measured to reduce the 
number of freeze/thaw cycles. The time from collection until centrifugation did not exceed 
two hours. 
 
Blood collection from fetal lambs was by cardiac puncture immediately post-mortem into a 
syringe. Fetal blood was then transferred from the syringe into evacuated blood tubes 
containing appropriate anticoagulant, mixed well and processed in an identical manner to that 
described for adult animals. 
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3.1.2 Measurement of live weight and body condition score 
Live weight to ± 0.5 kg was measured by placing animals individually in an appropriate-sized 
holding crush fitted with electronic scales. 
Body condition score was assessed by visual appraisal using a standard scale of 1 (emaciated) 
to 5 (obese). To ensure consistency, body condition score in ewes and red deer hinds was 
assessed by one person (M. Ridgway, Lincoln University) on all occasions throughout the 
studies described in this thesis. 
3.2 Hormone assays 
In all cases, the entire set of samples from an individual animal was processed in duplicate in 
a single assay to minimise any impact of interassay variation. Detailed methods for all assays 
are described below. 
3.2.1 Natriuretic peptides 
NP concentrations were determined by radioimmunoassay (RIA) performed at Christchurch 
Cardioendocrine Research Laboratory at the University of Otago, Christchurch, using in-
house assay protocols.  
Extraction of peptides from plasma 
NPs were extracted from plasma samples using Sep-Pak C18 columns (Walters, Milford, MA, 
USA). The columns were prepared by the addition of 5 ml of 100 % methanol followed by 5 
ml of 0.1 % trifluoroacetic acid (TFA). Plasma samples (1-4 ml) were then passed through the 
columns, followed by a further 5 ml of 0.1 % TFA. Peptides were eluted using 2 ml of 80 % 
isopropanol in 0.1 % TFA into polystyrene collection tubes containing 10 µl of 0.1 % Triton 
X-100 (addition of Triton to the collection tubes prevents binding of  NPs to the tube). The 
eluant was collected, dried at 37 °C under an air stream and frozen at -20 °C. 
 
Extraction of peptides from uteroplacental tissues 
Samples of frozen uterine and placental tissue (approximately 1 g) were finely diced on a 
chilled plastic chopping board, weighed and gently boiled for 5 minutes in 10 ml distilled 
water containing 10 µl Triton X-100. After boiling, the tissue suspension was cooled by 
immediately placing on ice. After cooling, 610 µl of glacial acetic acid was added and the 
tissue suspension homogenised (4 x 20 second bursts at 24,000 rpm) using an Ultra-Turrax 
homogeniser (IKA-Labortecknik, Staufen, Germany). The tissue homogenates were then 
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centrifuged (3000 g, 4 °C, 30 minutes), extracted over SepPac C18 columns and assayed in an 
identical manner to that for plasma samples. 
 
CNP 
CNP was assayed as previously described (Yandle et al., 1993; Prickett et al., 2007), with 
minor changes: 50 µl standard (human proCNP(82-103)) or sample extract was preincubated 
with 50 µl of a commercial primary rabbit antiserum raised against proCNP (82-103) 
(Phoenix Pharmaceuticals Inc., Belbont, CA, USA. Catalogue #RAB–014–03) and diluted to 
1:3000, then incubated for 22-24 hours prior to the addition of 50 µl of tracer  
(125I labelled Tyr0-proCNP(82-103)) containing 1500 cpm. Within- and between-assay 
coefficients of variation were 6.6 % and 8.6 % respectively at 1.1 pmol l-1. The detection limit 
and EC50 for this assay was 0.4 and 6.1 pmol l-1 respectively. 
 
NTproCNP 
NTproCNP was measured as previously described (Prickett et al., 2001; Prickett et al., 2007) 
with the following alterations: 100 µl standard or sample extract was preincubated with 50 µl 
primary rabbit antiserum raised against NTproCNP (1-15) (J39, diluted 1:6000) then 
incubated for 22-24 hours prior to addition of 50 µl of tracer(125I labelled proCNP(1-15)Tyr16) 
containing 1500 cpm. Following a further 22-24 hour incubation period, bound and free 
labelled antigen were separated by addition of  500 µl of solid phase secondary antibody (5 % 
v/v Donkey anti-Rabbit Sac-cell (IDS Ltd, UK) diluted in assay buffer containing 5 % w/v 
dextran). Peptide standards were made from synthetic human proCNP(1-19) taking into 
account the purity data supplied (Chiron Technologies Pty Ltd, Australia). Within- and 
between-assay coefficients of variation were 7.5 % and 7.9 % respectively at 24 pmol l-1. The 
detection limit and EC50 for this assay was 1.3 and 58 pmol l-1 respectively. 
 
ANP 
ANP was measured as described previously (Yandle et al., 1986), with the following 
modifications: 50 µl standard/sample was preincubated with 50 µl of primary rabbit antiserum 
diluted to 1:10000, to which 50 µl  of tracer was added after a 24 hour incubation period. 
Bound and free labelled antigen were separated by addition of 500 µl of solid phase 
secondary antibody (5 % v/v Donkey anti-Rabbit Sac-cell (IDS Ltd, UK) diluted in assay 
buffer containing 2 % polyethylene glycol). After 15 minutes incubation at room temperature, 
tubes were centrifuged at 4 °C for 15 minutes, and radioactivity of the pellet counted 
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following aspiration of the supernatant. The detection limit and EC50 for this assay was 10.5 
and 31 pmol l-1 respectively.  
 
NTproBNP 
NTproBNP was measured by RIA as described previously (Pemberton et al., 1998) with the 
following alterations: 50 µl  standard/sample was preincubated with 50 µl  of primary rabbit 
antiserum raised against synthetic ovine proBNP and diluted to 1:3000, to which 50 µl  of 
tracer was added after a 24 hour incubation period. Bound and free labelled antigen were 
separated by addition of 500 µl of solid phase secondary antibody (5 % v/v Donkey anti-
Rabbit Sac-cell (IDS Ltd, UK) diluted in assay buffer containing 2 % polyethylene glycol). 
After 30 minutes incubation at room temperature, tubes were centrifuged at 4 °C for 15 
minutes, and the pellet counted following aspiration of the supernatant. The detection limit 
and EC50 for this assay was 9.7 and 65 pmol l-1 respectively. 
 
3.2.2 Other hormone assays 
Progesterone 
Plasma progesterone concentration was measured in triplicate 50 µl aliquots by enzyme-
linked immunosorbent assay (ELISA) as described by Anderson and Barrell (1998). Within- 
and between-assay coefficients of variation were 6.1 % and 14.9 % respectively. 
 
Oestradiol 
Plasma oestradiol concentration was measured in a commercial laboratory (Endolab, 
Canterbury District Health Board, Christchurch, New Zealand) by RIA using a commercial 
kit (E2 – Estradiol-2; Sorin Biomedica, Saluggia, Italy). Within- and between-assay 
coefficients of variation were 9.7 % and 20 % respectively at 41 pmol l-1. The detection limit 
and EC50 for this assay was 4.5 and 130 pmol l-1 respectively. 
 
-Hydroxybutyrate 
Plasma -OHB concentration was measured in a commercial laboratory (Gribbles Veterinary 
Pathology, Christchurch, New Zealand) on a Hitachi Modular analyser using an enzymatic 
method based on the change in absorbance which occurs following oxidation of  
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D-3-hydroxybutyrate by 3-hydroxybutyrate dehydrogenase, and concomitant reduction of 
NAD+ to NADH (Randox Ranbut D-3-Hydroxybutyrate Manual, Randox Laboratories Ltd., 
County Antrim, United Kingdom). 
Glucose 
Plasma glucose concentration was measured photometrically by a commercial laboratory 
(Lincoln University, Lincoln, New Zealand) using a Roche Hitachi Cobas Mira Plus analyser. 
Urea 
Plasma glucose concentration was measured by a commercial laboratory (Lincoln University, 
Lincoln, New Zealand) using a kinetic UV assay performed on a Roche Hitachi Cobas Mira 
Plus analyser. 
Insulin-like growth factor-1 
IGF-1concentration in fetal plasma was measured by a commercial laboratory (Endolab, 
Canterbury District Health Board, Christchurch, New Zealand) by RIA. Briefly, 100 µl of 
plasma extract (previously extracted using hydrochloric acid and ethanol) or human IGF-1 
standards (Novoenzymes GroPep, receptor grade) were incubated with anti-human IGF-1 
antiserum (1:6000; Novoenzymes GroPep) together with an excess insulin-like growth  
factor-2 (IGF-2) (Novoenzymes GroPep, animal media grade) overnight at 4 ºC. 100 µl  
125I-labelled IGF-1 (Novoenzymes GroPep, receptor grade) was added and samples incubated 
overnight at 4 ºC.  globulin was added, and bound and free radioactivity separated using 
polyethylene glycol followed by centrifugation for 15 minutes at 4000 rpm at 4 ºC. The inter-
assay CV for this assay was 10 %. 
 
3.3 Size-exclusion high performance liquid chromatography 
(HPLC) 
Placental tissue samples were extracted in an identical manner as for NP RIA.  The extracts 
were then resuspended in 20 % acetonitrile containing 0.1 % TFA and subjected to size 
exclusion HPLC using a G3000 (Toyo Soda, Tokyo, Japan, 7.5 x 600 mm) column 
equilibrated with 20 % acetonitrile in 0.1 % TFA at a 0.5 ml/minute flow rate. Eluted 
fractions were collected at one minute intervals into test-tubes containing 10 µl 0.1 % Triton 
X-100. The HPLC fractions were dried at 37 °C under an air stream and then assayed for CNP 
as described for plasma samples. 
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    Chapter 4: 
Maternal circulating CNP forms during pregnancy 
Declaration 
The majority of the content of this chapter has been published in the journal articles McNeill 
et al. (2009a) and McNeill et al. (2010). I was involved in all aspects of the study design and 
animal procedures.  With the exception of the oestradiol assay, all hormone assays were 
conducted by me. The writing of the published manuscripts which form this chapter included 
contributions from co-authors, and benefited from the comments and suggestions of 
anonymous reviewers.  
4.1 Abstract 
Circulating concentrations of CNP are elevated in late-gestation ewes but the time course of 
these changes and relation to fetal maturation are unknown. Maternal plasma concentrations 
of CNP and NTproCNP were monitored at weekly intervals from preconception to 3 weeks 
postpartum in ewes with twins (n = 8), and in non-pregnant ewes (n = 8) studied similarly. In 
contrast to low and stable values in non-pregnant ewes (CNP 0.75 ± 0.08, NTproCNP  
22 ±2 pmol l-1 ), in pregnant ewes CNP forms increased abruptly at 40-50 days of gestation 
and rose progressively to peak values (CNP 31 ± 5 pmol l-1, NTproCNP 270 ± 16 pmol l-1)  at 
about day 120. Approximately 7 days pre partum, the concentration of both CNP forms fell 
precipitously to preconception values immediately postpartum. An identical study of red deer 
hinds carrying singletons (n = 8) showed similar patterns though the peak maternal 
concentration of both CNP (2.14 ± 0.2 pmol l-1 ) and NTproCNP (132 ± 9.5 pmol l- 1 ) was 
much lower. In a separate study of pregnant ewes, maternal plasma concentrations of CNP 
forms at day 120 were found to be positively related to fetal number - consistent with a major 
contribution from the utero-placental unit. These findings - the first report of maternal 
circulating CNP forms throughout pregnancy in any species - in showing an abrupt rise 
coinciding with placentation, and sharp decline within days of parturition, support a 
significant role of CNP in placental and fetal maturation in ruminants. 
4.2 Keywords 
C-type natriuretic peptide, NTproCNP, pregnancy, placenta, fetus, sheep, red deer 
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4.3 Introduction  
CNP, a member of the NP family of structurally related peptides, is a paracrine/autocrine 
factor with important roles in cardiovascular homeostasis and skeletal development. CNP and 
its receptor, NPR-B, have also been identified in uterine and placental tissues and in both 
male and female gonads (reviewed by Walther & Stepan, 2004). Moreover in mice, uterine 
CNP mRNA expression is stimulated by oestradiol (Acuff et al., 1997) and CNP 
concentration in ovarian tissues fluctuates with the oestrous cycle (Jankowski et al., 1997). 
These findings suggest that CNP may be of particular importance in female reproductive 
biology.  
 
Recent studies by Prickett et al. (2007) show that maternal circulating concentrations of CNP 
are some 50-fold higher in late gestation ewes when compared with non-pregnant control 
sheep. Plasma concentrations of the (presumably) biologically inactive form of CNP, 
NTproCNP, were also elevated at least 10-fold. A major contribution by utero-placental 
tissues to these high systemic concentrations was suggested by high veno-arterial CNP 
gradients across the gravid uterus (Prickett et al., 2007), and significant correlation between 
maternal NTproCNP with placental weight (Prickett et al., 2007). These findings in sheep 
contrast with those in humans where evidence of strong CNP gene expression in placental and 
uterine tissues (Walther & Stepan, 2004) is not reportedly reflected by elevation in plasma 
CNP concentration in healthy women during pregnancy (Walther & Stepan, 2004). 
 
Postulating that in sheep the time course of maternal plasma concentration of CNP forms 
during pregnancy may provide insights to placental and fetal maturation, the aim of the 
current study was to conduct a longitudinal survey, from preconception to parturition, of 
maternal plasma CNP forms in healthy ewes and to compare the findings to normal non-
pregnant ewes studied under identical conditions.  A parallel study was conducted in red deer 
to establish whether the hormone profile in sheep may be common to ruminants or is unique 
to ovine pregnancy. Additionally, the hypothesis that CNP secretion has a positive 
relationship with fetal number was tested by measuring maternal circulating CNP and 
NTproCNP concentration in late gestation ewes with single-, twin- and triplet-pregnancies.  
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4.4 Methods 
4.4.1 Longitudinal survey  
Fifty-three Coopworth, or Coopworth x South-Hampshire cross ewes (Ovis aries) and fifteen 
red deer hinds (Cervus elaphus) of mixed age were randomly selected from the Lincoln 
University Research Farm for this study. Animals were grazed outdoors at the Lincoln 
University Research Farm, Canterbury, New Zealand, with supplementary feed supplied 
during winter. Synchronisation of the oestrous cycle was achieved using intravaginal 
progesterone-releasing devices (‘Eazi-breed’ type G CIDRs. Pfizer New Zealand Ltd., 
Auckland) in accordance with published protocols for sheep (Wheaton et al., 1993) and deer 
(Rhodes et al., 2003). On the day of mating, ewes were randomly allocated into two groups 
and run with two crayon-harnessed entire rams (pregnant group, n = 32) or with a crayon-
harnessed vasectomised ram (control group n = 21). Hinds were also randomly allocated into 
two groups and run either with an entire red deer stag (pregnant group, n = 10) or as hinds 
only (control group, n = 5). Pregnant and non-pregnant animals were reunited five weeks later 
and run together for the remainder of the study.  Confirmation of pregnancy was determined 
by ultrasonography in early gestation and subsequent birth of a lamb or deer calf. As 
conception dates were estimates, results are expressed in relation to actual parturition date. 
 
Blood samples were collected weekly beginning one week preconception until three weeks 
postpartum (and throughout the same time period from non-pregnant ewes and hinds) for 
measurement of plasma CNP and NTproCNP concentration (ewes and red deer hinds). 
Plasma concentration of oestradiol and progesterone was also measured in pregnant ewes. 
Plasma concentration of ANP and NTproBNP was measured in a randomly-selected 
subsample of pregnant (n = 4) and non-pregnant (n = 4) ewes. Non-fasting live weights were 
recorded fortnightly. 
 
4.4.2 Effect of number of fetuses  
Mixed-age natural-mated Suffolk, Perendale or Corriedale ewes from the Lincoln University 
Research Farm were examined by transabdominal ultrasonography on approximately day 94 
of pregnancy. Ewes were marked according to the number of fetuses detected by the scanning 
procedure. At approximately day 120 of pregnancy, ewes with a single-, twin- or triplet- 
pregnancy (20 of each category) were selected at random and a single blood sample was 
collected from each of the 60 animals.  
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4.4.3 Statistical analyses 
Statistical analyses were performed using Systat version 7.0 (SPSS Inc., Chicago Il, USA). A 
P value of  0.05 was considered statistically significant. Changes in CNP and NTproCNP 
during pregnancy were determined using one-way repeated measures ANOVA with time as 
the independent variable. Two-way repeated measures ANOVA was used to determine 
changes in ANP and NTproBNP concentration over time, and to identify differences between 
pregnant and non-pregnant animals. Differences in hormone concentration with number of 
fetuses were determined by one-way ANOVA. Data were log-transformed where appropriate 
to meet ANOVA assumptions. Bonferroni post hoc analyses were performed for both the 
longitudinal and number of fetuses studies.  
4.5 Results 
An excess number of ewes were included in the longitudinal study to allow for animals failing 
to become pregnant, death or illness of mother and/or neonates, and differing number of 
fetuses. Because single fetuses were under represented, their number being insufficient to 
allow statistical evaluation, the study groups were confined to healthy twin-bearing ewes with 
normal pregnancy and delivery, and healthy non-pregnant control ewes. From each of these 
two groups, 8 animals were chosen at random for completion of hormone profiles (Figure 
4-1). Likewise, hormone profiles are presented for 8 healthy single-bearing red deer hinds and 
4 non-pregnant control hinds (Figure 4-2). One red deer calf presented for delivery in a breech 
position and birth assistance was required, but this did not appear to have an adverse effect on 
either the calf or its dam, or on results presented here.   
 
4.5.1 Live weight and birth weights of lambs and fawns 
All animals used in the longitudinal study had weight gain profiles and birth weights 
consistent with normal pregnancy for red deer and Coopworth sheep on this farm (data not 
shown).  
 
 23
4.5.2 Maternal circulating hormone concentration throughout pregnancy 
4.5.2.1 CNP and NTproCNP 
Plasma concentrations of CNP and NTproCNP increased significantly during pregnancy in 
ewes (P < 0.01, Figure 4-1) and hinds (P < 0.01, Figure 4-2). One week preconception, 
plasma CNP concentration was 0.98 ± 0.06 and 1.03 ± 0.03 pmol l-1 in ewes and hinds, 
respectively. Plasma NTproCNP concentration was 27.2 ± 1.07 (sheep) and 16.2 ± 1.18 (deer) 
pmol l-1. In pregnant ewes, circulating concentrations of CNP and NTproCNP became 
significantly elevated above pre-pregnancy values by 115 and 110 days before parturition, 
respectively (ovine gestation length is approximately 145 days) (P < 0.001 CNP; P = 0.04 
NTproCNP). Peak plasma concentration of CNP (31 ± 5 pmol l-1) and NTproCNP (270 ± 16 
pmol l-1) was observed at around 30 days before parturition, followed by a significant decline 
in the concentration of  both peptide forms (7 days before parturition; CNP 36 % of peak,  
P < 0.001; NTproCNP 71 % of peak, P = 0.006). A similar pattern was observed in pregnant 
hinds, although the magnitude of the rise in concentration was much smaller. Plasma 
NTproCNP concentration became significantly elevated (P < 0.001) above pre-pregnancy 
levels by 171 days before parturition (cervine gestation length is approximately 233 days), 
whereas the increase in CNP concentration was not significant until 94 days before parturition 
(P < 0.05).  Peak plasma NTproCNP concentration (132 ± 9.5 pmol l-1) was recorded 38 days 
before parturition, whereas the peak CNP concentration (2.14 ± 0.2 pmol l-1) did not occur 
until 10 days before parturition. Concentrations of both CNP forms appeared to decline in the 
final week of cervine pregnancy, although this did not reach statistical significance. In both 
species, circulating CNP and NTproCNP concentrations returned to pre-pregnancy values 
immediately after parturition (P = NS).  
 
In non-pregnant ewes there was a small but significant change in plasma concentration of 
CNP (P = 0.014) and NTproCNP (P < 0.001) during the study period (Figure 4-1). There were 
no significant changes in the concentration of either peptide form in non-pregnant hinds 
during the study (P = NS, Figure 4-2).  
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Figure 4-1. Plasma NTproCNP a nd CN P concentratio n in twin-bearing preg nant a nd non- pregna nt ewes. 
Mean (± SEM) plasma (A) NTproCNP and (B) CNP concentration in twin-bearing pregnant 
(closed circles) and non-pregnant (open circles) ewes (n = 8). Day of pregnancy refers to 
pregnant animals. *, Significant difference from pre-pregnancy baseline; #, significant change in 
mean concentration in the final 2 weeks of gestation. Parturition occurred at day 0. 
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Figure 4-2. Plasma NTproCNP a nd CN P concentratio n in preg nant a nd non- pregna nt red deer hinds. 
Mean (± SEM) plasma (A) NTproCNP and (B) CNP concentration in pregnant (n = 8) (closed 
circles) and non-pregnant (n = 4) (open circles) red deer hinds. Day of pregnancy refers to 
pregnant animals. *, Significant difference from pre-pregnancy baseline. Parturition occurred at 
day 0. 
 
 
4.5.2.2 ANP and NTproBNP 
There was no change in either ANP or NTproBNP concentration in maternal plasma during 
ovine pregnancy (P = NS, Figure 4-3), nor was there any difference in plasma concentration 
of these peptides between pregnant and non-pregnant ewes at any stage (P = NS). 
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Figure 4-3. Plasma ANP a nd N TproBNP concentration in twin- bearing pregna nt a nd no n-pregna nt ewes. 
Mean (± SEM) plasma (A) ANP and (B) NTproBNP concentration in twin-bearing pregnant 
(closed circles) and non-pregnant (open circles) ewes (n = 4). Day of pregnancy refers to 
pregnant animals. Parturition occurred at day 0. 
 
4.5.2.3 Oestradiol and progesterone 
Mean plasma oestradiol concentration declined steadily during the 1st trimester (Figure 4-4). 
Thereafter, the values fluctuated but there was a marked elevation during the final week of 
pregnancy before falling sharply at parturition.  
 
An increase in mean plasma progesterone concentration commenced soon after mid-gestation 
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declined progressively (Figure 4-4).  After parturition both oestradiol and progesterone were 
barely detectable in the maternal venous plasma.  
 
 
Figure 4-4. Plasma oestradio l a nd progesterone concentratio n in twin-bearing preg nant ewes t hroug ho ut the course of gestatio n. 
Mean (± SEM) plasma (A) oestradiol and (B) progesterone concentration in twin-bearing 
pregnant ewes (n = 8) throughout the course of gestation. Parturition occurred at day 0. 
 
4.5.3 Effect of fetal number 
The number of fetuses had a significant positive effect on the maternal concentration of 
circulating CNP forms, with the highest concentrations measured in triplet-bearing ewes 
(CNP P < 0.001; NTproCNP P < 0.001) (Figure 4-5). 
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Figure 4-5. Plasma concentratio n of NTproCNP a nd CNP at around day 120 of gestation in ewes carrying o ne, two or three fetuses. 
Mean (± SEM) plasma concentration of (A) NTproCNP and (B) CNP at around day 120 of 
gestation in ewes carrying one (n = 23), two (n = 20), or three (n = 17) fetuses. 
 
4.6 Discussion 
This chapter describes the first longitudinal study of maternal circulating CNP forms 
throughout pregnancy in any species. In confirming previous findings of greatly raised 
concentrations in late gestation in the ewe (Prickett et al., 2007), the present results extend our 
knowledge of CNP’s participation in ruminant pregnancy by showing an abrupt increase 
coinciding with placentation followed by a progressive rise until near-term in two ruminant 
species, sheep and red deer. In addition they show a direct relationship between maternal 
concentration of CNP forms and fetal number, and a marked decline in maternal 
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concentrations during the final week of pregnancy. These observations strongly support a role 
for CNP in placental and fetal maturation and preparation for parturition and serve as a basis 
for future in vivo studies of CNP’s functional role. 
 
In both ewes bearing twins and hinds with a single fetus, venous plasma NTproCNP 
concentration increased abruptly towards the end of the 1st trimester - in strong contrast to the 
much lower and unchanging concentration of NTproCNP in non-pregnant adult control 
animals. In ewes, the initial rate of increase in plasma NTproCNP concentration was greater 
than that of CNP but increases in both forms slowed some 90-60 days before parturition (at a 
gestational age of 55-85 days). Of interest, similar patterns of change are observed in plasma 
nitric oxide (NO) (Vonnahme et al., 2005) and may be associated with reduced oestrogen 
production during the same period (Carnegie & Robertson, 1978). After mid-gestation, the 
rate of increase in maternal CNP concentration exceeded that of NTproCNP. Whether these 
differential changes in CNP forms in ewes relate to reduced activity of degradative pathways, 
including NPR-C (which is downregulated in uterine arteries in late gestation) (Itoh et al., 
1998), neutral endopeptidase or possibly associated with the phase of rapid fetal growth is 
unclear. Although CNP synthesis is high in the fetus, any contribution of the fetus itself to 
maternal levels is unlikely as the fetal lamb plasma concentration of CNP (3.8 ± 0.2 pmol l-1) 
is much lower than maternal levels and appears to be regulated independently (Prickett et al., 
2007). 
 
The dramatic changes in circulating CNP forms were in stark contrast to ANP and 
NTproBNP, which remained low for the duration of pregnancy and showed no difference 
from non-pregnant controls. An increase in BNP has been reported previously in maternal 
plasma during normal human pregnancy (Franz et al., 2009; Hameed et al., 2009), with the 
rise attributed to volume overload as a consequence of the marked increase in maternal blood 
volume during pregnancy (Hameed et al., 2009). Reports of elevated maternal ANP 
concentration have been reported in human pregnancy, although this reported rise may be an 
artefact of inappropriate study design and an increase in ANP during pregnancy remains to be 
demonstrated conclusively (Reviewed by Steegers, 1991). Similarly, previous reports of ANP 
and BNP concentration in the pregnant ewe have been inconclusive (Cheung et al., 1987) or 
show little or no change during the course of pregnancy (Lubbers & Eghtesady, 2007). The 
results of the current study are supported by these earlier studies and suggest that these 
peptides do not play an important role in ovine pregnancy. 
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The present study was not designed to determine the mechanisms underlying the dramatic 
changes observed in maternal CNP concentrations, nor their functional consequences. 
Nonetheless, the time sequence and close correlation of plasma concentration of CNP forms 
with fetal number strongly substantiate previous findings (Prickett et al., 2007) and indicate 
that uteroplacental tissues are an important source. Of note, the initial increase in maternal 
NTproCNP concentration in ovine pregnancy corresponds to the phase of maximum placental 
growth and invasion of the maternal stroma (Ehrhardt & Bell, 1995). In mice, there is 
abundant CNP expression closely associated with the maternal blood vessels of the placenta 
(Cameron et al., 1996) - possibly initiated by increases in shear stress (Zhang et al., 1999). 
This localisation suggests a role for the hormone in angiogenesis (Doi et al., 1997; Yamahara 
et al., 2003) and vasodilation (Suga et al., 1993). Indeed, later in gestation it seems likely that 
both the local (auto/paracrine) actions within placenta and uterus (Acuff et al., 1997; Walther 
& Stepan, 2004), as well as endocrine contributions from high circulating CNP concentrations 
(Charles et al., 1995), all contribute to the massive increase in uteroplacental blood flow 
associated with the pregnant state (Reynolds & Redmer, 1995; Itoh et al., 1998).  
 
In this context, increased oestrogen production is known to be important in maintaining 
vasodilation (Rosenfeld et al., 1996). The effects of oestrogens are mediated in part by NO 
but the changes in this pathway are considered to be insufficient to account for the increases 
in uterine blood flow observed in late gestation (Rosenfeld et al., 1996). Oestradiol increases 
CNP gene expression in the murine uterus (Acuff et al., 1997) and also stimulates plasma 
CNP forms in adult (non-pregnant) ewes (Espiner et al., 2008). Together these findings raise 
the possibility that some of oestradiol’s actions on uterine blood flow may be mediated by 
CNP. While this may be true after mid-gestation, it is notable that the initial increases in 
NTproCNP occur during a period of declining plasma oestradiol concentration, making it 
unlikely that oestradiol is the main driver of CNP synthesis in pregnancy. Clearly separating 
uterine from placental sources of CNP will be an important future objective.  
 
A striking observation in the present study is the precipitous decline in the plasma 
concentration of both CNP forms in ewes during the final week of pregnancy, with a similar 
downward trend evident in deer. The time sequence of these changes coincides with the 
period of rapid hypothalamus-pituitary-adrenal activation in the fetus (Barnes et al., 1978). 
The rise in fetal plasma cortisol concentration in lambs commences around 15 days before 
delivery (Barnes et al., 1978) and is associated with progressive induction of placental  
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17-hydroxylase, and fall in maternal plasma progesterone as observed here. Conceivably the 
upsurge in fetal cortisol secretion in the final 3-5 days (Barnes et al., 1978) may be sufficient 
at the placental tissue level to down regulate CNP expression. Glucocorticoids can rapidly 
inhibit CNP synthesis in vivo (Prickett et al., 2005; Prickett et al., 2008a), and the possibility 
that similar inhibition can occur at the much lower concentrations of glucocorticoids attained 
near term awaits further study. In any event, the current findings suggest that inhibiting CNP 
once the fetus is mature may be an important step in preparing for parturition - for example by 
reducing vasodilation (Suga et al., 1993) and potential blood loss associated with placental 
separation. 
 
In this study of ruminant pregnancy, sheep and deer exhibited similar profiles in circulating 
maternal CNP forms - both species showing a steeper rise in CNP concentration after mid- 
gestation. However, plasma CNP concentration - similar in the 2 species prior to conception - 
was much lower in pregnant deer. Thus the peak CNP concentration in deer was 
approximately 2-fold preconception values compared with the 30-fold elevation in ewes. 
Presumably these differences reflect enhanced degradation rates of CNP in pregnant deer - 
possibly by placental proteases such as neutral endopeptidase (Kikkawa et al., 2002) - since 
the amino acid sequence of CNP-22 is likely to be identical in deer and sheep. On the other 
hand, the lower concentration of peak NTproCNP measured in deer (some 100 pmol l-1 lower 
than that recorded from single-bearing ewes in late gestation) could be based on differences in 
amino acid sequence in proCNP 1-50. Although both proteins eluted during HPLC at the 
expected position of the 5 KDa protein (Prickett et al., 2003), precise quantitation of deer and 
sheep NTproCNP requires knowledge of the sequence in deer and use of the appropriate 
standards in RIA.  
 
Of note, plasma concentrations of CNP and NTproCNP in non-pregnant animals were very 
similar in sheep and deer, suggesting that the apparent difference in peptide concentration 
between the two species during gestation can not be explained entirely by assay specificity. 
Structural differences between sheep and deer placentae may instead be a contributing factor. 
In particular, although the basic structure of the placenta is conserved in the two species, the 
oligocotyledonary placenta of deer consists on average of only ten placentomes whereas the 
polycotyledonary ovine placenta often has 100 or more placentomes (Klisch & Mess, 2007), 
indicating that there may be fundamental species differences in placental function at the level 
of the placentome. Possibly, the reason for these species differences will become apparent as 
our understanding of the role of CNP in pregnancy improves. 
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Regarding speciation, it is relevant to note that maternal values of plasma CNP concentration 
in human pregnancy (at term) do not appear to be different from those measured in non-
pregnant adult women (Walther & Stepan, 2004). There are no reports of longitudinal studies 
of CNP concentration (nor of NTproCNP) during gestation in humans but Stepan et al. (1998) 
report that maternal plasma CNP concentration  did not increase with gestational age in a 
cross sectional study . Many factors including placental structure and production of other key 
hormones during pregnancy may account for these differences. However more focused and 
serial measurements of both CNP forms in pregnant women would seem to be indicated in the 
light of the subtle but significant changes in maternal CNP observed here in deer hinds. 
 
The current findings in pregnant ewes, together with evidence of reciprocal changes in fetus 
(in which CNP falls) and ewe (in which CNP rises) during nutritional stress (Prickett et al., 
2007), strongly support the view that CNP is carefully regulated in pregnancy and that change 
in maternal plasma CNP concentration, at least in sheep, may reflect local utero-placental 
secretion and fetal distress. On this hypothesis, higher circulating CNP concentration with 
increasing fetal number in ewes at day 120 gestation may be seen as an adaptive change to 
fetal nutrient restriction. This view is reinforced by the finding that fetal plasma CNP 
concentration is lower in a twin when compared with that in a single fetus (Prickett et al., 
2007). In late-gestation ewes carrying twin and triplet fetuses, nutritional requirements are 
120 % and 140 % above maintenance, respectively (Bell et al., 2005), which if not met, will 
result in caloric restriction. Although total blood flow and placenta size are greater in multiple 
pregnancies, when these factors are evaluated on a per fetus basis, they are actually lower than 
in single fetus pregnancies (Ferrell & Reynolds, 1992), with the same being true of lamb 
weight, placental weight, placental efficiency and cotyledon number (Dwyer et al., 2005). 
Furthermore, as the total placental weight increases with increasing litter size, so too do its 
metabolic demands. Therefore, the larger but less efficient placenta in twin-bearing ewe may 
consume more energy for its own metabolic needs and transfer relatively less to the 
developing fetus (Dwyer et al., 2005), further compromising fetal nutrient uptake.  
 
Reduced energy uptake by twin and triplet fetuses can result in a state of hypoxia (Ferrell & 
Reynolds, 1992; Etchernkamp et al., 2006). CNP production is stimulated by hypoxia 
(Scotland et al., 2005), and elevated CNP in multiple pregnancies may be an adaptive 
response by the placenta to promote vasodilation and increase blood flow to ensure that fetal 
energy demands are being met in adverse conditions. Similar mechanisms may be the basis 
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for higher maternal concentrations of NTproCNP, and lower fetal values, in women 
presenting with preeclampsia when compared with normal pregnant women at term (Prickett 
et al., 2004). Clearly these hypotheses now require experimental support, possibly using 
models of placental insufficiency. 
 
In conclusion, this study reveals that concentrations of CNP forms are greatly elevated in 
maternal circulation during pregnancy in two species of ruminant; sheep and red deer. The 
pattern of hormone production, and positive relationship with fetal number suggest that CNP 
is produced by uteroplacental tissues in response to placental and fetal maturation. These 
findings suggest that CNP has important roles in ruminant pregnancy, elucidation of which 
may provide new insight into the role of the hormone in other species.  
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    Chapter 5: 
CNP production in ovine placenta 
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trophoblast binucleate cells was conducted by Dr FBP Wooding at the Centre for Trophoblast 
Research, University of Cambridge, UK.  
* McNeill, BA; Barrell, GK; Wooding, FBP; Prickett, TCR and Espiner, EA. (2011) The 
trophoblast binucleate cell is the source of maternal circulating C-type natriuretic peptide in 
ovine pregnancy. Placenta In press 
 
5.1 Abstract 
Maternal plasma concentrations of CNP and NTproCNP are elevated during ovine pregnancy. 
Although the uteroplacental unit has been implicated as a likely source of CNP, the relative 
contributions of specific uterine and placental tissues, and identity of the cellular site/s of 
production remain unknown. Therefore, CNP and NTproCNP concentration was measured in 
intercaruncular uterine tissue and maternal (caruncle) and fetal (cotyledon) placental tissues 
throughout gestation. Concentrations of CNP forms in placental tissues greatly exceeded 
those in intercaruncular uterine tissue throughout pregnancy (P < 0.05). Mean caruncular 
concentrations (CNP 32 ± 4, NTproCNP 56 ± 6 pmol g-1) peaked at day 60 whereas in the 
cotyledon there was a progressive increase in CNP forms to peak values (CNP 66 ± 6, 
NTproCNP 134 ± 9 pmol g-1) at day 100-135 followed by a sharp decline just prior to term 
(day 143). At term CNP gene expression was 6-fold greater in placental tissue compared with 
intercaruncular uterine tissue. Changes in maternal plasma concentration of CNP forms 
closely followed those in cotyledonary tissue whereas fetal plasma levels fell progressively 
throughout gestation. Immunohistochemistry revealed staining in trophoblast BNCs and 
around placental blood vessels.  
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CNP’s localization to the BNC suggests a novel endocrine role during pregnancy, in addition 
to its paracrine actions within the placental vasculature. The function of CNP in maternal 
circulation remains to be determined, but as proposed for other BNC products, may involve 
manipulation of maternal physiology and placental function to favour fetal growth. 
 
5.2 Keywords 
C-type natriuretic peptide, NTproCNP, pregnancy, placenta, fetus, sheep, binucleate cell 
 
5.3 Introduction 
During ovine and cervine pregnancy, maternal circulating concentrations of CNP increase at 
the end of the first trimester to levels exceeding 20 pmol l-1 before rapidly declining during the 
final week of gestation (Chapter 4). The temporal pattern of CNP forms in maternal 
circulation (Chapter 4) and high venoarterial concentration gradient across the gravid uterus 
(Prickett et al., 2007) strongly implicate the uteroplacental unit as an important source of 
maternal CNP during pregnancy. However the relative contributions from uterine and 
placental tissues are unknown, as is the identity of the cell type/s within the placenta 
responsible for CNP production.  
 
A unique feature of the ruminant placenta is the presence of large, granulated binucleate cells 
of fetal placental origin which appear at the time of implantation and persist for the remainder 
of pregnancy. BNC are formed from uninuclear trophoblast cells which can undergo 
horizontal division resulting in one daughter cell without a tight junction attachment. This cell 
then undergoes nuclear division and is released from the trophoblast basement membrane, 
thus becoming a potentially motile cell which differentiates into the characteristic, heavily 
granulated binucleate phenotype (Wooding, 1982). In ovine pregnancy, the mature BNC 
migrate through the trophoblast tight junction and fuse with individual uterine epithelial cells 
or their derivatives. This gradually replaces the uterine epithelium with a fetomaternal hybrid 
syncytium formed by these migrating BNC and the uterine epithelial cells (Wooding, 1982). 
The cytoplasmic contents of the BNC fuse into the fetomaternal syncytium and the contents 
of the characteristic BNC granules are released by exocytosis at the basal plasmalemma of the 
original uterine epithelial cell, from where they diffuse into the maternal circulation. This 
provides a method of hormone delivery from fetal placental tissue to mother without apparent 
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activation of any maternal immune response (reviewed in Wooding, 1992; Wooding & 
Burton, 2008).  
 
Preliminary experiments from our laboratory demonstrated that CNP and NTproCNP protein 
concentration in the fetal portion of the placenta (cotyledon) exceeded that in the maternal 
aspect (caruncle) in near-term ewes, despite a higher peptide concentration in maternal versus 
fetal plasma (McNeill et al., 2009a). This finding, taken with the similarity between the 
pattern of CNP production during pregnancy and abundance of BNC in the ovine placenta 
(Wooding, 1982), suggests that CNP may be a product of these unique cells of pregnancy. 
Therefore, the aim of the current study was to further our understanding of CNP’s role in 
ovine pregnancy by characterising the pattern of CNP expression in uterine and placental 
tissue at early, mid- and late-pregnancy and to address the hypothesis that maternal circulating 
CNP is produced by fetal BNC.  
 
5.4 Methods 
5.4.1 Collection of tissue and plasma samples 
Mixed-age Coopworth ewes of known gestational age from the Lincoln University Research 
Farm carrying single (n = 9) or twin (n = 11) lambs were killed by captive bolt gun on day 30, 
60, 100, 135 and 143 of pregnancy (n = 4 at each time-point, term = day 145). In the case of 
twins, samples of plasma and placental tissue were collected from each fetus and the hormone 
concentration averaged to give a single value for that animal. Prior to slaughter, a maternal 
blood sample was collected from each ewe. Fetal blood samples were collected immediately 
after slaughter at all time-points except day 30, when the fetal blood volume was too low to 
enable measurement of CNP forms. The uterus was excised and four randomly-selected 
placentomes were removed from each ewe as well as four samples of intercaruncular uterine 
tissue. In order to determine the individual contribution of maternal and fetal tissues to 
placental CNP concentration, the maternal (caruncle) and fetal (cotyledon) aspects of the 
placentome were separated at the time of tissue collection. This was achieved by gently 
pulling on the two sides of the placentome, yielding a clean separation of the two tissues. At 
day 135, samples of skeletal muscle (gracilis), intercaruncular uterine tissue and placental 
tissue were also collected for measurement of CNP gene expression. After dissection, all 
tissues were immediately frozen by immersion in liquid nitrogen and stored at -80 °C. Eight 
mixed-age non-pregnant Coopworth ewes were also killed at similar times (corresponding to 
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days 30 and 135 in the pregnant group, n = 4 at each time-point). Blood and uterine 
caruncular and intercaruncular tissue samples were collected from these animals and stored in 
an identical manner as for the pregnant ewes. 
 
5.4.2 CNP gene expression  
Total RNA was isolated using TRIzol (Invitrogen). Tissue samples (~300 mg) were 
homogenised by grinding in a Retsch MM301 tissue mill at 30 Hz for 10 minutes in 800 µl 
TRIzol. First-strand cDNA was synthesized from 1 g total RNA with Superscript III reverse 
transcriptase (Invitrogen). Quantitative real-time PCR analyses were performed with a Rotor-
Gene RG-3000 real-time PCR machine (Corbett Research, Sydney, Australia). The CNP 
transcript was detected and quantified with the following set of primers: 5-
CAGAAGAAGGGCGACAAGAC-3 (sense) and 5-CCCTTGGACAAACCCTTCTT-3 
(antisense) – amplified product size 179 bp. PCRs were performed in a total volume of 20 µl 
containing 1 µl cDNA, 0.4 mM primers, 0.3 l AccuPrime Taq DNA polymerase 
(Invitrogen), 1x PCR buffer I, 0.2 mM deoxynucleotide triphosphates, 4 l 5 x Q solution 
(Qiagen) and 1 l (1:5000 dilution) Sybr Green 1 (Roche). Following a hot start at 96 °C for  
2 minutes, each sample underwent 45 cycles of annealing at 60 °C for 35 seconds, extension 
for 30 seconds at 72 °C, and denaturation at 90 °C for 30 seconds. Samples were assayed in 
duplicate and gene expression levels quantified against a standard curve and expressed as pg 
of message per microgram of total RNA.  
 
5.4.3 Immunohistochemistry  
In order to investigate site/s of CNP localisation within the placentome, whole placentomes 
were collected from twin-bearing Coopworth ewes and processed for immunohistochemistry. 
Samples were collected at approximately day 124 of pregnancy, frozen in liquid nitrogen and 
stored at -80 °C. Placentomes were embedded in optimal cutting temperature compound and 
sectioned at 6 µm. Endogenous peroxidise activity was blocked by incubation in 1 % peroxide 
solution for 20 minutes at room temperature. Slides were washed three times in phosphate 
buffered saline solution (PBS) containing 1 % normal goat serum and incubated with primary 
antibody (CNP 1:250; NTproCNP 1:500) or PBS (negative control) overnight at 4 °C. The 
slides were then subjected to successive overnight incubations at 4 °C - first with biotinylated 
secondary antibody (1:1000) followed by a second incubation with an extravidin-HRP 
complex (1:1000). A PBS washing step was performed between each incubation. The slides 
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were then washed in HRP reaction buffer prior to staining using HRP substrate solution (30 
minute incubation at room temperature followed by dehydration steps using a series of 
alcohols and xylene) in preparation for viewing by microscopy. 
 
To determine whether CNP is a product of the trophoblast BNC, additional studies were 
performed in Cambridge using araldite resin-embedded sections to locate CNP, NTproCNP 
and pregnancy associated glycoprotein (PAG). PAG is produced only by the fetal trophoblast 
BNC and therefore served as a positive control for identification of these cells.Two Welsh 
Mountain ewes were mated naturally and killed with an overdose of sodium pentothal at 80 
days of pregnancy. After laparotomy the uterus was cut out, the fetus removed and the uterine 
and umbilical arteries cannulated in turn and perfused with 1 % glutaraldehyde plus 4 % 
formaldehyde in 0.1 M phosphate buffer and finally embedded in epoxy (araldite) resin by 
standard procedures (Wooding et al., 2007). For immunocytochemistry, 1 m resin sections 
were picked up on aminopropyltriethoxysilane coated coverslip pieces and dried at 60 °C for 
30 minutes. Resin was removed from the epoxy resin sections by flotation on sodium 
ethoxide (15 g NaOH in 15 ml absolute ethanol) for 15 minutes. The sections were washed 
with 100 % alcohol, and then sequentially floated on 50 % alcohol, PBS, PBS plus 1 % 
bovine serum albumin (the blocking solution and diluent for all antibodies), and finally on 
antibody solution (polyclonal CNP 1:50; NTproCNP 1:50; PAG M4 1:1000 (Wooding et al., 
2007); monoclonal SBU3 1:1000 (Wooding et al., 2007)) overnight at 4 °C.  
After mouse monoclonal antibody incubation and a PBS wash, the sections were floated on 
rabbit anti-mouse serum (Dako Ltd., Ely, Cambridgeshire, UK) diluted 1:1000 for  
30 minutes, washed with PBS and then joined by the polyclonal incubations on goat anti-
rabbit 5 nm gold colloid solution (Stratech Scientific, Soham, Cambridgeshire, UK; diluted 
1:40) for 40 minutes. All sections were washed with PBS and then water, left on water for 10 
to 30 minutes, and finally transferred to the silver intensification reagent (Amersham Intense 
M) (15 to 25 minutes) to increase the size of the initial gold (monitored by eye) for light 
microscope visualization. The sections were then water washed and dried, counterstained with 
acidified 1 % Fast Green solution, and finally mounted section side down in Biomount (BBI, 
Cardiff, UK). Antibody controls replaced the antibody or lectin with equivalent non-specific 
solutions or omitted the gold colloid or intensification stages. Digital photomicrographs were 
taken on a Zeiss Axiomat microscope. 
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5.4.4 Statistical analyses 
Differences between maternal and fetal plasma hormone concentrations were determined by 
two-way ANOVA and Bonferroni post hoc test. Differences in hormone concentration 
between uteroplacental tissues, and changes in hormone concentration over time within 
tissues, were determined using a restricted maximum likelihood (REML) test and a method of 
statistical differentials using day of gestation and number of fetuses as the dependent 
variables. Data were log-transformed where appropriate and a P value of  0.05 was 
considered statistically significant. Analyses were performed using Genstat Version 10 (VSN 
International Ltd., Hemel Hempstead, UK). 
 
5.5 Results 
5.5.1 CNP and NTproCNP in uteroplacental tissues 
CNP and NTproCNP concentrations in uteroplacental tissues are expressed per gram of tissue 
(wet weight) extracted. The concentration of both CNP forms in placental tissues (cotyledon 
and caruncle) exceeded those in intercaruncular uterine tissue at all stages of gestation  
(P < 0.05, Figure 5-1and Table 5-1). Within the placenta, the concentration of CNP and 
NTproCNP was higher in the fetal cotyledon compared with the maternal caruncle at days 30, 
100 and 135 of pregnancy (P < 0.01). Caruncular CNP and NTproCNP concentrations were 
lowest at day 30, rising to peak concentration at day 60 before declining (day 100) and 
remaining steady thereafter. In contrast, the concentration of CNP and NTproCNP in the 
cotyledon increased progressively from day 30 until day 135, before declining sharply just 
prior to term (P < 0.05).  
 
In the uterus, the concentration of CNP and NTproCNP was low and unchanging throughout 
pregnancy except for values obtained on day 30 (0.72 ± 0.17 and 3.4 ± 1.2 pmol g-1 
respectively) which were increased and significantly higher (P < 0.05) than concentrations of 
CNP (0.26 ± 0.1 pmol g-1) and NTproCNP (0.42 ± 0.17 pmol g-1) in non-pregnant 
intercaruncular uterine tissue. There was no difference in the concentration of CNP forms 
between pregnant and non-pregnant intercaruncular uterine tissue at any other stage of 
pregnancy (P = NS, data not shown). Similarly caruncular concentrations of CNP forms in 
non-pregnant ewes were not different from intercaruncular concentrations at either sampling 
period (P = NS). There was no effect of fetal number on the concentration of NTproCNP in 
uterine or placental tissues (P = 0.2). In contrast, there was evidence of a significant effect of 
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fetal number on CNP concentration in these tissues (P < 0.05), reflecting a trend for higher 
concentrations of CNP in cotyledon extracts from single- versus twin-bearing ewes at days 
100 and 135. 
 
 
Figure 5-1. Protein co ncentration of N TproCNP  and CNP in intercarunc ular uterine tissue, maternal caruncle and fetal cotyledon.  
Mean (+ SEM) protein concentration of (A) NTproCNP and (B) CNP in intercaruncular uterine 
tissue (white bars), maternal caruncle (grey bars) and fetal cotyledon (black bars), n = 4 for 
each. Differences between tissues at each time-point are summarised in Table 1. 
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Table 5-1. Summary of differences in CNP a nd NTproCNP co ncentration in uterine a nd place ntal tissues during o vine pregna ncy. 
Summary of differences in CNP and NTproCNP concentration in uterine and placental tissues 
during ovine pregnancy. 
Day of pregnancy Comparison P-value 
 
 CNP NTproCNP 
30 uterus vs caruncle < 0.01 < 0.001 
30 uterus vs cotyledon < 0.001 < 0.001 
30 caruncle vs cotyledon 0.001 < 0.001 
60 uterus vs caruncle < 0.001 < 0.001 
60 uterus vs cotyledon < 0.001 < 0.001 
60 caruncle vs cotyledon NS 0.02 
100 uterus vs caruncle < 0.001 < 0.001 
100 uterus vs cotyledon < 0.001 < 0.001 
100 caruncle vs cotyledon < 0.001 < 0.001 
135 uterus vs caruncle < 0.001 < 0.001 
135 uterus vs cotyledon < 0.001 < 0.001 
135 caruncle vs cotyledon < 0.001 < 0.001 
143 uterus vs caruncle < 0.001 < 0.001 
143 uterus vs cotyledon < 0.001 < 0.001 
143 caruncle vs cotyledon NS < 0.001 
 
5.5.2 CNP gene expression in placental and uterine tissues  
CNP mRNA expression at day 135 was similar in placental cotyledon and caruncular tissue, 
and greatly exceeded that observed in intercaruncular uterine tissue (P < 0.001) and skeletal 
muscle (Figure 5-2). 
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Figure 5-2. CNP mRNA levels in t issues obta ine d from pregna nt ewes at day 135 of gestation.  
Mean (+ SEM) CNP mRNA levels in tissues obtained from pregnant ewes at day 135 of 
gestation, (n = 3, 4 replicate samples per tissue source from each animal). Quantitated gene 
levels are expressed as picograms of message per microgram of total RNA (pg/µg total RNA). 
 
5.5.3 Plasma concentration of CNP forms in mother and fetus 
As shown in Figure 5-3, in contrast to the increasing concentrations of CNP forms in the 
maternal circulation, there was a progressive decline in the concentration of both peptides in 
fetal circulation during gestation. In the fetus, the concentration of CNP forms was highest at 
day 60 – i.e. at first sampling. Circulating CNP concentration was higher in maternal 
compared with fetal plasma at all time-points (P < 0.05, Figure 5-3), and maternal circulating 
NTproCNP was higher than fetal from day 100 onwards (P < 0.05). Maternal circulating CNP 
concentration increased between day 30 and day 100. Coinciding with the decline in 
cotyledonary CNP concentration (Figure 5-1), plasma CNP concentration fell abruptly just 
before term (P < 0.001). Maternal circulating NTproCNP concentration increased between 
day 30 and day 60 (P < 0.001) and remained elevated for the duration of pregnancy. 
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Figure 5-3. Plasma concentratio n of NTproCNP a nd CNP in the maternal  and fetal circulations.  
 Mean (+ SEM, n = 4) plasma concentration of (A) NTproCNP and (B) CNP in the maternal 
(white bars) and fetal (black bars) circulations. Except where indicated by ns, the concentration 
of both CNP forms was significantly higher in the maternal compared with fetal circulation. 
 
5.5.4 Cellular localisations of CNP forms in placental tissue 
As shown in Figure 5-4, in sections processed from frozen tissue, strong staining for both 
CNP and NTproCNP was evident in the placentome, particularly in cells surrounding 
placental blood vessels. Staining was absent in control sections. Figure 5-5 shows sections 
prepared after resin embedding, and demonstrates that CNP (Figure 5-5 c) and NTproCNP 
(Figure 5-5 b) are strongly labelled in a minority of BNC, and when seen, are colocalised with 
PAGs (Figure 5-5 a and d) as shown on the semi-serial sections. No labelling was seen on 
control sections (Figure 5-5 e). 
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Figure 5-4. Immuno histoc hemical loca lisatio n of N TproCNP  and CNP in cotyle do n trophoblasts a nd vasc ular tissue a nd negative co ntrol at da y 124 of pregna nc y. 
Immunohistochemical localisation of (A) NTproCNP and (B) CNP in cotyledon trophoblasts and 
vascular tissue and (C) negative control 
200 µm. Note deposition of stain surrounding blood vessel near centre of the figure in A and B.
 
 
on frozen sections at day 124 of pregnancy. Bar equals 
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 Figure 5-5. Immunocytoche mistry demonstrating t he co-localisation of CNP and N TproCNP w ith t he two PAGs, SBU3 a nd M3 , in the sa me BNCs o n se mi-serial sections. 
Immunocytochemistry of deresinated sections prepared after aldehyde perfusion, fixation and 
araldite embedding. The arrows demons
(5b) with the two PAGs, SBU3 (5a) and M3
Control section (5e) prepared with non
blood vessel; asterisks: artefactual separation of the microvillar junction between trophoblast 
and fetomaternal syncytium. Bar (5a) equals 60 µm.
 
5.5.5 Relationship between CNP forms in maternal circulation and fetal 
cotyledon 
When subjected to size exclusion HPLC/RIA, a major 
a position consistent with CNP
with CNP-22 was also identified. As shown in 
trate the co-localisation of CNP (5c), and NTproCNP 
 (5d), in the same BNCs on semi
-specific antibody. fbv: fetal blood vessel; mbv: maternal 
 
peak of immunoreactive CNP eluted in 
-53 (Figure 5-6 A). A smaller peak (fractions 31
Figure 5-6 B, a major peak of immunoreactive 
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-serial sections. 
–33) consistent 
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proCNP 1-15 eluted in a position consistent with the 5-kDa (or similar) aminoterminal 
fragment (proCNP 1-50). A smaller (unidentified) and later eluting peak was also present. The 
early eluting shoulder (fractions 22–25) of immunoreactive material identified in both Figure 
5-6 A and B is consistent with the presence of proCNP (1–103). 
 
 
Figure 5-6. Immunoreactive NTproCNP a nd CNP size exclus ion HP LC profi les of ovine placental extract from day 14 3 of gestatio n 
Immunoreactive (ir) (A) NTproCNP and (B) CNP size exclusion HPLC profiles of ovine 
placental extract from day 143 of gestation. Column void volume (V0) and elution positions of 
molecular markers are shown by arrows. 
 
Comparison of the concentration of CNP forms in the fetal cotyledon (current study) with 
maternal circulating CNP forms throughout pregnancy (Chapter 4) revealed a strong 
similarity in the temporal pattern of CNP in these two situations (Figure 5-7).  
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Figure 5-7. Concentratio n of N TproCNP and CNP in t he materna l circulation a nd fetal cotyledo n.  
Mean (± SEM) concentration of (A) NTproCNP and (B) CNP in the maternal circulation () and 
fetal cotyledon (white bars). 
 
5.6 Discussion 
This study reports a number of novel observations relating the concentration of CNP peptides 
in placental and uterine tissues to blood concentrations throughout gestation in ovine 
pregnancy - findings that contrast with the progressive decline in their concentration in fetal 
plasma. Importantly, for the first time the trophoblast BNC has been identified as an 
important source of CNP during pregnancy. Collectively, the evidence of sustained and 
increasing participation of (placental) paracrine and (maternal) endocrine CNP activity, in the 
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face of decreasing CNP concentration in the fetal circulation, point to separate and distinct 
actions in the dam and the fetus. 
 
Using well-recognised immunohistochemical techniques, both CNP and NTproCNP were 
localised to trophoblasts and vascular tissue in the ovine placentome. The identity of CNP-
positive BNCs is confirmed by the co-localised staining of CNP forms and the BNC marker 
PAG. Ruminant BNC are capable of producing a variety of steroid and other hormones 
(Wooding, 1992), but this is the first study to report localisation of CNP to these cells, 
strongly implicating them as a site of production of this peptide.  Of note, obvious CNP 
peptide-specific staining was observed in a minority of BNCs in contrast to the more 
prevalent staining of PAG. Presumably the much higher concentrations of PAGs (nanomolar 
versus picomolar for CNP (Kappes et al., 1992)) contribute to this apparent discrepancy. 
Other factors such as the lability of CNP (half-life less than 2 minutes (Charles et al., 1996)) 
and loss of antibody binding epitopes in the course of immunocytochemical processing are 
additional factors reducing positive labelling on the resin sections. The demonstration of 
staining of both CNP and NTproCNP around the placental blood vessels on the frozen 
sections, a site of prominent CNP gene expression in the mouse embryo (Cameron et al., 
1996), suggests that CNP has two distinct roles during pregnancy; exerting its effect in an 
endocrine fashion in the maternal circulation and also acting as a paracrine/autocrine factor 
within the placental vasculature. 
 
A striking result of this study is the close temporal relationship between changes in the 
concentration of CNP forms in the fetal cotyledon and in maternal plasma throughout the 
course of gestation. An exception applies to samples drawn on day 30 where, for both CNP 
forms, the ratio of maternal plasma concentration to placental content is comparatively low, 
suggesting a possible impairment of secretory ability at this early stage of placental 
development. Although the relative weights of the caruncle and cotyledon were not recorded 
in the current study, previous reports indicate that cotyledonary mass is generally 2-3 times 
greater than caruncular mass (Reynolds et al., 2005a). Taken together with the 
immunolocalisation of CNP and PAG to the BNC, these data strongly implicate the fetal 
placenta as the primary source of maternal circulating CNP during ovine pregnancy. A similar 
temporal relationship between maternal and placental ovine placental lactogen (oPL) has been 
reported, where oPL mRNA expression in the cotyledon was related to maternal, but not to 
fetal serum oPL concentration (Kappes et al., 1992). Although the precise function of BNC-
derived oPL and PAG has not been confirmed, it appears that oPL may promote fetal growth 
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by manipulating maternal metabolism to favour preferential delivery of glucose from mother 
to fetus (Byatt et al., 1992). A function for PAG in cell adhesion and immunomodulation at 
the feto-maternal interface has been proposed (Wooding et al., 2005). Of note, there was 
some evidence of higher CNP concentrations in uteroplacental tissues in single- versus twin-
bearing ewes. This result is in contrast to the positive relationship between maternal CNP 
concentration and fetal number reported in Chapter 4, indicating that further work with larger 
numbers in the two groups is required to investigate a possible effect of fetal number on 
placental CNP concentration. 
 
The similarities between the site of production and temporal secretion of oPL (Kappes et al., 
1992) and CNP as demonstrated in the current study, provide new evidence to suggest that 
CNP may also represent a communication from the fetus to its dam, presumably for the 
benefit of the fetus. This view is further supported by the previous finding of increased 
maternal concentrations as fetal levels fall in response to acute nutrient deficiency in late 
ovine gestation (Prickett et al., 2007). Infusion studies will be an important next stage to 
identify the physiological effects elicited by CNP in the pregnant female, which may include 
maintenance of myometrial quiescence (Carvajal et al., 2009) and mediating a reduction in 
peripheral vascular resistance as blood volume expands. On the other hand, CNP’s role as a 
predominantly paracrine/autocrine factor likely contributes importantly to the greatly 
increased blood flow to uteroplacental tissues during pregnancy (Cameron et al., 1996; Itoh et 
al., 1998). In addition to its vasodilatory function, CNP is also a potent inhibitor of vascular 
smooth muscle cell growth (Furuya et al., 1991) and may therefore be involved in regulation 
of uteroplacental vascular development, a process which must be carefully controlled during 
pregnancy to prevent the development of pathological conditions associated with excessive 
capillary growth (Reynolds & Redmer, 2001).  
 
Until the current report, the relative changes in CNP production within uterine and placental 
tissues during ovine pregnancy were unknown. In the current study, CNP protein 
concentrations in ovine uterine tissue were low and stable as gestation proceeded to term, 
apart from a transient increase early in pregnancy coinciding with the phase of rapid uterine 
growth (Spencer et al., 2004). These results are in sharp contrast to the progressive increase in 
uterine CNP mRNA reported in murine pregnancy (Stepan et al., 2001). Furthermore, the 
finding of low CNP gene expression in uterine tissue – similar to skeletal muscle at term – 
provides further evidence of different patterns of uterine CNP production in the two species. It 
has been suggested that augmented uterine CNP expression in murine pregnancy reflects 
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increasing oestrogen production which is known to stimulate CNP gene transcription in 
rodent uterine tissue (Acuff et al., 1997). In previous studies in non-pregnant sheep, oestrogen 
has been identified as a potent stimulus of CNP secretion (Prickett et al., 2008b). However the 
lack of an association of uterine CNP content to fluctuations in plasma oestradiol 
concentration during ovine pregnancy (Chapter 4) suggests that alternative mechanisms 
regulate CNP production within uterine tissues in ovine pregnancy. 
 
The current study is the first to document the time course of CNP forms in fetal plasma in any 
species, from early in the 2nd trimester through to term. In marked contrast to the increase in 
placental and maternal concentrations during the same period, both CNP and NTproCNP 
declined progressively in the fetus to attain concentrations at term approximating 40 % (CNP) 
and 60 % (NTproCNP) of initial values observed on day 60.This is a very similar decline to 
that shown for oPL in the fetal circulation (Chan et al., 1978). These findings, and the absence 
of a concentration gradient of CNP across the fetal umbilical artery and vein (McNeill et al., 
2009b), constitute strong evidence that the sheep placenta is not a source of CNP in the fetal 
circulation. Conceivably, changes in distributional volume (plasma volume per body weight 
increases with fetal maturation), and/or increased degradation could contribute to the 
observed decline in fetal CNP forms. However, evidence that fetal concentrations fall during 
acute caloric restriction (Prickett et al., 2007), and during physiological increments in fetal 
cortisol levels (Prickett et al., 2010a), indicates that CNP production itself is likely to be 
carefully regulated. Since the peptide is widely expressed in fetal tissues (Stepan et al., 2001), 
future studies using trans-organ regional sampling should help to clarify tissue contributions 
to circulating levels. It is interesting to note that whereas maternal concentrations of CNP 
forms in humans (Prickett et al., 2004) appear to differ markedly from those in pregnant 
sheep, fetal concentrations at term are very similar (3-4 pmol l-1). Furthermore, the umbilical 
vein concentration of NTproCNP is inversely related to gestational age in both humans and 
sheep and the concentration ratio of NTproCNP to CNP in fetal plasma is some 5-6 fold that 
in the maternal circulation (Prickett et al., 2008a). These observations suggest that circulating 
CNP concentration in the fetus is tightly regulated. 
 
Equally intriguing is the role of CNP in the fetal circulation. A possible role in longitudinal 
growth has been proposed due to the relationship between fetal CNP concentration and linear 
growth rate in humans (Prickett et al., 2008a) and the crucial role for CNP in postnatal 
skeletal development (Chusho et al., 2001). However, the pattern of CNP in fetal circulation 
does not reflect ovine patterns of linear growth, which are characterised by accelerated growth 
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in the final stages of pregnancy (Barbera et al., 1995) - a period of decreasing circulating CNP 
in the fetus. Furthermore, as discussed by Prickett et al. (2007), in CNP-knockout mice the 
skeletal effects of disrupted CNP signalling are generally not evident at birth, and manifest 
only during the postnatal growth period. In keeping with this view, recent studies in the fetal 
lamb (Prickett et al., 2010b) suggest that changes in fetal growth and plasma NTproCNP 
concentration during glucocorticoid administration are less tightly coupled than in the 
postnatal period but further study of these relationships are clearly needed in humans and 
other mammals. 
 
In conclusion, positive localisation of CNP to the trophoblast BNC is reported during ovine 
pregnancy, suggesting an important new endocrine role for CNP in the pregnant female. The 
direct relationship between maternal circulating CNP concentration and placental peptide 
production indicates that measurement of maternal concentrations may provide a novel tool 
for monitoring feto-placental well-being and identifying at-risk pregnancies. This study has 
revealed a new mediator of fetal-maternal communication in ruminant pregnancy with 
possible relevance to understanding the regulation of placental function in other species as 
well. 
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    Chapter 6: 
Regulation of CNP during ovine pregnancy – the role of 
nutrition 
Declaration 
I was involved in all aspects of the design, execution and analysis of the experiment described 
in this chapter. Furthermore, all CNP and NTproCNP assays were performed by me. Other 
analytes were assayed by Gribbles Veterinary Pathology Laboratories (-OHB), Lincoln 
University (glucose, urea, progesterone) or Canterbury District Health Board (IGF-1). I 
received significant technical assistance with sample collection and animal procedures as well 
as comments on drafts of this chapter from my PhD supervisors. 
6.1 Abstract 
Extremely high concentrations of CNP and NTproCNP occur in the maternal circulation 
during ruminant pregnancy; probably arising from production by the BNC of the placental 
trophoblast. As further increases in maternal circulating CNP forms have been reported during 
fasting in late pregnancy, the aim of this study was to test the hypothesis that CNP production 
by the uteroplacental unit is homeostatically regulated by its nutritional status. At day 85 of 
pregnancy, twin-bearing ewes were allocated to one of three treatment groups: caloric 
restriction (CR, n = 10, fasted between days 121-124 of pregnancy), caloric loading (CL, n = 
6, fed to 200 % of ME requirements between days 110-124 of pregnancy) or control (n = 10, 
fed to 100 % of ME requirements). Maternal blood samples were collected twice weekly from 
day 80 until day 100 and then daily until day 124. At day 124 of pregnancy, ewes were killed 
and samples of fetal plasma, uterine and placental tissues collected. Maternal circulating 
NTproCNP concentration, expressed as a percentage of  pre-fasting concentration (day 121), 
was significantly elevated 24 hr later in CR ewes compared with controls (117 ± 5.1 % vs 107 
± 3.5 %, P < 0.05). Fetal plasma CNP and NTproCNP concentrations were lower in CR 
compared with control fetuses (CNP: 4.6 ± 0.28 vs 5.2 ± 0.23 pmol l-1; NTproCNP: 191.5 ± 
5.9 vs 208.8 ± 5.1 pmol l-1, P < 0.05). Fetal weight was also reduced in CR fetuses (P = 0.02). 
There was no effect of dietary manipulation on the concentration of CNP forms in uterine or 
placental tissues. There was no effect of CL on the concentration of either CNP form in 
plasma or uteroplacental tissues (P = NS), despite a significant increase in maternal body 
condition score and fetal plasma IGF-1 concentration (P < 0.05).  
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The results of this study do not support the hypothesis that CNP production during pregnancy 
is homeostatically regulated by nutrition, instead they suggest that production of the peptide is 
selectively upregulated by caloric restriction. 
6.2 Keywords 
Sheep, placenta, CNP, NTproCNP, caloric loading, caloric restriction  
6.3 Introduction 
Extremely high concentrations of CNP and NTproCNP have been identified in plasma and 
placental extracts from pregnant ruminants, suggesting that CNP is likely to be involved in 
fetal and/or placental development. However, the role of CNP during pregnancy and the 
factor/s involved in regulating its production have not been identified. In ewes, Prickett et al. 
(2007) reported a significant increase in maternal circulating CNP and NTproCNP 
concentration following a three-day fast in late gestation, which was reversed on refeeding. 
This finding was used to formulate the hypothesis that the increase in CNP production may be 
an adaptive response by the uteroplacental unit, as part of a homeostatic mechanism 
regulating nutrient supply to the conceptus. 
 
Therefore, the aim of the current study was to test this hypothesis; by monitoring the effects 
of nutrient restriction (maternal fast) and, conversely, abundance (caloric load) on plasma and 
placental concentrations of CNP forms in late pregnancy. In keeping with the hypothesis, it is 
proposed that caloric loading during ovine pregnancy will result in a decrease in the 
concentration of CNP forms in maternal plasma. In contrast, maternal circulating 
concentrations of CNP forms are expected to increase following nutrient restriction. Having 
identified the trophoblast BNC as a likely source of CNP in maternal circulation (Chapter 5), 
it is hypothesised that changes in maternal plasma concentration of CNP forms will be 
reflected by similar changes in CNP protein concentration within the cotyledon. 
 
6.4 Methods 
6.4.1 Animals 
Mixed-age Coopworth ewes of known gestational age from the Lincoln University Research 
Farm were used in this study. Pregnancy was confirmed and fetal number determined by 
transabdominal ultrasonography at day 70 of pregnancy, at which time the first 30 ewes from 
a large mob scanned as carrying twin fetuses were selected for inclusion in the study.  
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6.4.2 Feeding details 
Prior to day 70 of pregnancy, all ewes were fed ad libitum on pasture. Between days 70 and 
80 of pregnancy the ewes remained on pasture but were provided with supplementary pellets 
(concentrate diet consisting of 13.5 MJ/kg, 85 % dry matter; providing the complete dietary 
requirements for pregnant ewes. Weston Animal Nutrition, Rangiora, New Zealand) to allow 
them to become accustomed to the concentrated feed. On day 80 of pregnancy all ewes were 
transferred to an indoor animal housing facility with individual pens and fed only pellets for 
the remainder of the experiment. Feed requirements in terms of ME were determined 
according to live weight, stage of pregnancy and number of fetuses using the method 
described by Nicol and Brookes (2007). Feed allowances were calculated on an individual 
basis for each ewe and were adjusted weekly as pregnancy progressed. Fresh water was 
available at all times throughout the study period. 
 
On day 80 of pregnancy ewes were allocated to one of three treatment groups (n = 10 per 
group): control, caloric restriction (CR) or caloric loading (CL). Allocation to groups was 
random but balanced for live weight. Control ewes were fed to requirement until slaughter at 
day 124 of pregnancy. CR ewes were also fed to requirement until day 121, after which they 
were fasted for three days until slaughter at day 124. CL ewes received their requirement feed 
until day 94 of pregnancy, thereafter gradually increasing to 200 % of requirement by day 110 
of pregnancy and fed at that level until slaughter at day 124 of pregnancy. 
 
Ewes were fed once daily in the morning after collection of a blood sample. As voluntary 
intake of CL ewes did not reach the desired level of 200 % of ME requirements, these ewes 
were provided their daily feed allowance in two equal allocations, in the morning and in the 
afternoon, in an attempt to encourage increased food intake. Fresh feed was provided daily to 
all animals and refusals were weighed to determine individual feed intakes. 
 
6.4.3 Blood samples and live weight measurements 
Maternal blood samples were collected twice weekly between days 84 and 100 of pregnancy 
and then daily from day 101 until slaughter for measurement of circulating CNP, NTproCNP, 
glucose, -OHB and urea concentrations. On all occasions, blood samples were collected in 
the morning, between 8 and 10 am. A fetal blood sample was collected immediately after 
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slaughter on day 124 of pregnancy for measurement of plasma CNP, NTproCNP and IGF-1 
concentration. 
 
Non-fasting live weights were recorded weekly from day 70 until day 110 of pregnancy, and 
then twice weekly from day 110 until slaughter. A final live weight and body condition score 
were recorded on day 124 immediately prior to slaughter. 
 
6.4.4 Tissue collection and slaughter procedure 
All ewes were killed by captive bolt followed by exsanguination on day 124 of pregnancy. 
The pregnant uterus was excised immediately after slaughter and samples of intercaruncular 
uterine tissue, caruncle and cotyledon collected and processed for measurement of CNP and 
NTproCNP protein concentration as described in Chapter 5. Placentomes were separated into 
A-, B-, C- and D-type according to the classification of Vatnick et al. (1991). As the majority 
of placentomes were A-type and everted placentome types were infrequent or absent in many 
ewes, CNP protein concentration was measured only in A-type placentomes. Two randomly-
selected A-type placentomes were collected from regions of placenta associated with each 
fetus (a total of four placentomes per ewe). CNP and NTproCNP concentration was measured 
in each of these four samples and the results averaged to give a single value for each ewe.  
 
Fetal weight, sex and crown-rump length were recorded immediately following collection of a 
fetal blood sample. Total placental weight - taken as the combined weight of all placentomes 
(cotyledon plus caruncle) - was recorded as well as the total number and weight of 
placentomes in each category.  
 
6.4.5 Statistical analyses 
Statistical analyses were performed using Genstat Version 10 (VSN International; Hemel 
Hemstead, UK). A P value of  0.05 was considered statistically significant. Data were log-
transformed where appropriate to meet ANOVA assumptions. Differences in maternal feed 
intake, live weight and maternal CNP concentration were assessed by 2-way repeated 
measures ANOVA followed by Bonferroni post hoc tests with treatment group and day of 
gestation as fixed effects. Differences in the concentration of CNP forms and IGF-1 in fetal 
plasma between control and treatment groups were determined by one-tailed unpaired t-test. 
Effect of diet on maternal glucose, urea and -OHB concentration were analysed by one-way 
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ANOVA followed by Bonferroni post hoc test. Relationships between plasma and tissue CNP 
forms and fetal and placental characteristics were examined by fitting the data with linear 
regression best-fit models and testing the deviation from zero slope using an F-test. 
 
6.5 Results 
6.5.1 Maternal feed intake, live weight and condition score 
Maternal feed intake and live weight throughout the study period are shown in Figure 6-1. 
There was no difference in feed intake between the three groups at the beginning of the study 
(P = NS). By day 97 feed intake in the CL group was significantly elevated above that of 
controls (P < 0.001) and remained elevated for the remainder of the study (P < 0.05), with the 
exception of days 106, 108, 110, 112, 115 and 117. Although CL ewes were offered 200 % of 
ME requirements, voluntary intake was lower than this; with a mean daily intake of 126.6 ± 
2.7 % of ME requirements between days 95 and 124 of pregnancy. Four ewes in the CL group 
consistently had feed intakes of less than 100 % of requirements and were therefore excluded 
from the study. There was no significant difference in live weight between the three groups of 
ewes at any time point except at day 124, at which time CL ewes were significantly heavier 
than CR ewes (P < 0.05). Maternal body condition score at slaughter was significantly higher 
in CL ewes compared with controls (P < 0.001, Figure 6-2). There was no difference in body 
condition score between CR and control ewes (P = NS). 
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Figure 6-1. Maternal feed inta ke a nd live weight in pregna nt ewes from control,  caloric loa ding a nd caloric restriction treatment gro ups.  
Mean (± SEM) (A) maternal feed intake (% ME requirement) and (B) live weight in pregnant 
ewes from control (closed circles, n = 10), caloric loading (open circles, n = 6) and caloric 
restriction (, n = 10) treatment groups. Feed allocation to ewes in the caloric loading group 
was gradually increased from 100 % to 200 % of ME requirements between days 95 and 110 of 
pregnancy. Significant difference (P < 0.05) from control values is indicated by an *. 
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Figure 6-2. Maternal body conditio n score of preg nant ewes at s laughter in ca loric restriction, control a nd caloric lo ading treat ment groups.  
Mean (+ SEM) maternal body condition score of pregnant ewes at slaughter in caloric 
restriction (n = 10), control (n = 10) and caloric loading (n = 6) treatment groups. 
 
6.5.2 Fetal and placental characteristics 
Fetal weight was significantly lower in CR fetuses compared with controls (P = 0.02, Figure 
6-3), and there was a trend for reduced crown-rump length in the CR fetuses (P = 0.07). There 
was no difference in fetal weight or crown-rump length between control and CL fetuses  
(P = NS, Figure 6-3). 
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Figure 6-3. Weig ht and crown-rump le ngth of sheep fetuses from caloric restriction, control a nd caloric loa ding treatme nt groups. 
Mean (+ SEM) (A) weight and (B) crown-rump length (CRL) of sheep fetuses from caloric 
restriction (n = 10), control (n = 10) and caloric loading (n = 6) treatment groups. Fetal weight 
represents the combined weight of both twins whereas crown-rump length is an average of each 
pair of twins. 
 
There was no difference in total placental weight or placental efficiency, calculated as the 
ratio of fetal:placental weight (Fowden et al., 2009), between the three treatment groups  
(P = NS, Figure 6-4). There were significantly fewer placentomes in CL compared with 
control ewes (P = 0.03), although there was no difference in average placentome weight 
between the two groups (P = NS). 
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Figure 6-4. Placental  weight, number of placento mes a nd placenta l efficiency at da y 124 of pregna ncy in pregna nt ewes from caloric restriction, co ntrol and caloric loading  treatment gro ups.  
Mean (+ SEM) (A) total placental weight (B) number of placentomes and (C) placental efficiency 
at day 124 of pregnancy in pregnant ewes from caloric restriction (n = 10), control (n = 10) and 
caloric loading (n = 6) treatment groups. 
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The placentae of all three groups consisted predominantly of A-type placentomes, accounting 
for 81, 69 and 76 % of all placentomes in the control, CR and CL groups, respectively. The 
frequency of each placentome type did not differ between the three treatment groups (P = NS, 
Figure 6-5).  
 
Figure 6-5. Placento me distributio n at day 1 24 of preg nancy in ewes fro m caloric restriction, co ntrol and caloric loa ding treatment gro ups.  
Mean (+ SEM) placentome distribution (%) at day 124 of pregnancy in pregnant ewes from 
caloric restriction (grey bars, n = 10), control (black bars, n = 10) and caloric loading (white 
bars, n = 6) treatment groups. 
 
6.5.3 CNP and NTproCNP concentration in maternal plasma 
Effect of CR 
There was no difference in maternal plasma concentration of either CNP form between 
control and CR ewes at day 85 of pregnancy (P = NS). However, immediately prior to fasting, 
circulating concentration of CNP forms were higher in control compared with CR ewes. 
Therefore, to allow comparison to be made between these two groups, the data were 
normalised to express fasting hormone concentration as a percentage of day 121 values 
(immediately prior to the commencement of the fasting period). This transformation revealed 
a significant elevation in maternal circulating NTproCNP concentration in CR ewes compared 
with control ewes on day 122 (P < 0.05, Figure 6-6). There was no change in maternal 
circulating CNP concentration between control and CR ewes during the fasting period (Figure 
6-6). Fasting was not associated with a change in the ratio of NTproCNP:CNP in maternal 
plasma (P = NS, Figure 6-6).  
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Figure 6-6. Cha nge in maternal  circulating N TproCNP a nd CNP co ncentration a nd mean mo lar plasma N TproCNP:CNP ratio  in pregnant ewes from control a nd caloric restriction treatment gro ups.  
Mean (± SEM) change in maternal circulating (A) NTproCNP and (B) CNP concentration 
expressed relative to day 121 values and (C) mean molar plasma NTproCNP:CNP ratio in 
pregnant ewes from control () and caloric restriction () treatment groups (n = 10 per group). 
The shaded area represents the fasting period. * P < 0.05 compared with control group. 
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Effect of CL 
There was no significant difference in maternal plasma concentration of either CNP form in 
control and CL ewes at the beginning of the study, before the period of caloric loading  
(P = NS), although there was a trend for lower maternal circulating concentration of CNP 
forms in CL ewes. Therefore, the data are expressed as a proportion of day 86 values to 
remove a possible confounding effect of this difference in baseline values (Figure 6-7). 
Analysis of both the raw data and normalised values revealed no significant difference in 
maternal circulating concentration of either CNP form between the control and CL groups at 
any time point (CNP: P = 0.6; NTproCNP: P = 0.7) 
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Figure 6-7. Cha nge in maternal  circulating N TproCNP a nd CNP co ncentration in pregna nt ewes from co ntrol and caloric loa ding treatment gro ups.  
Mean (± SEM) change in maternal circulating (A) NTproCNP and (B) CNP concentration 
expressed relative to day 86 values in pregnant ewes from control (closed circles, n = 10) and 
caloric loading (open circles, n = 6) treatment groups. Feed allocation to CL ewes was gradually 
increased from 100 % to 200 % of requirements between days 95-110. 
 
6.5.4 CNP and NTproCNP concentration in fetal plasma 
Maternal fasting was associated with significantly lower fetal plasma concentration of CNP  
(P = 0.05) and NTproCNP (P = 0.02) in CR fetuses compared with controls (Figure 6-8). 
There was no effect of CL on fetal plasma concentration of either CNP form (P = NS). 
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Figure 6-8. Plasma concentratio n of NTproCNP a nd CNP in ovine fetuses fro m caloric restriction, co ntrol and caloric loa ding treatment gro ups.  
Mean (+ SEM) plasma concentration of (A) NTproCNP and (B) CNP in ovine fetuses from 
caloric restriction (n = 10), control (n = 10) and caloric loading (n = 6) treatment groups. 
Hormone concentrations are averages for each pair of twins. 
 
6.5.5 CNP and NTproCNP concentration in uterine and placental tissue 
In all groups, the concentration of CNP forms in the placenta exceeded that in intercaruncular 
uterine tissue (P < 0.05). Within the placenta, the concentration of both CNP forms was 
higher in the cotyledon compared with the caruncle (P < 0.05). There was no effect of diet on 
the concentration of either CNP form in uterine or placental tissue at slaughter (P = NS, 
Figure 6-9). 
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Figure 6-9. Concentratio n of N TproCNP and CNP in uterine and materna l (caruncle) a nd fetal (cotyledon) placenta l tissues in preg na nt ewes from caloric restriction, co ntrol  and caloric loa ding treatment gro ups at day 124 of pregna ncy. 
Mean (+ SEM) concentration of (A) NTproCNP and (B) CNP in uterine and maternal (caruncle) 
and fetal (cotyledon) placental tissues in pregnant ewes from caloric restriction (grey bars, n = 
10), control (black bars, n = 10) and caloric loading (white bars, n = 6) treatment groups at day 
124 of pregnancy. Within each tissue type, diet had no effect on the concentration of either CNP 
form (P = NS). 
 
6.5.6 Relationship between CNP forms and fetal and placental weight 
There was a significant positive relationship between maternal plasma NTproCNP, but not 
CNP, concentration at slaughter and total placental weight (NTproCNP: r2 = 0.24, P = 0.01; 
CNP: r2 = 0.10, P = 0.13). There was also a significant positive relationship between maternal 
plasma NTproCNP concentration at slaughter and NTproCNP concentration in the cotyledon 
(r2 = 0.24, P = 0.01), but again no relationship between CNP concentration in maternal plasma 
and in the cotyledon (P = 0.99).  
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There was no relationship between fetal weight and maternal circulating concentration of 
either CNP form at slaughter (NTproCNP: P = 0.28; CNP: P = 0.07). Likewise, there was no 
relationship between fetal plasma concentration of either CNP form at slaughter and fetal 
weight (NTproCNP: P = 0.88; CNP: P = 0.96) or crown-rump length (NTproCNP: P = 0.85; 
CNP: P = 0.60). 
 
6.5.7 Maternal progesterone and maternal and fetal nutritional biochemistry 
Maternal progesterone:  
There was no difference in maternal circulating progesterone concentration between control 
and caloric loading groups at any time-point during the study period (P > 0.05, Figure 6-10). 
 
Figure 6-10. Maternal circulating  progesterone concentratio n in pregna nt ewes from control  and caloric loading groups.  
Mean (± SEM) maternal circulating progesterone concentration in pregnant ewes from control 
(closed circles, n = 10) and caloric loading (open circles, n = 6) groups. 
 
Maternal -OHB, glucose and urea:  
There was no difference in maternal plasma concentration of -OHB, glucose or urea between 
the three groups at the beginning of the study (day 85 of pregnancy), or immediately prior to 
the fasting period (day 121) (P = NS; Figure 6-11). Caloric restriction was associated with a 
significant increase in the circulating concentration of -OHB and urea, and a significant 
decrease in maternal plasma glucose concentration compared with controls (P < 0.05). Caloric 
loading was associated with a significant elevation in maternal plasma glucose concentration 
at day 122 of pregnancy (P < 0.05). 
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Figure 6-11. Maternal circulating  -hy droxy butyrate, glucose a nd urea concentratio n in pregna nt ewes from control,  caloric loa ding a nd caloric restriction groups.  
Mean (± SEM) maternal circulating (A) -hydroxybutyrate, (B) glucose and (C) urea 
concentration in pregnant ewes from control (closed circles, n = 10), caloric loading (CL) (open 
circles, n = 6) and caloric restriction (CR) (, n = 10) groups. Fasting in CR ewes commenced 
after collection of day 121 blood sample. CL commenced on day 95. (* P < 0.05,** P < 0.01, *** 
P < 0.001 compared with control group.) 
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Fetal IGF-1: 
IGF-1 concentration in fetal plasma was significantly reduced (P < 0.001) in CR fetuses, and 
significantly elevated (P < 0.05) in CL fetuses, when compared with controls (Figure 6-12). 
 
 
Figure 6-12. Insulin-like growth factor-1 concentration in ovine fetal pla sma in caloric restriction, co ntrol a nd ca loric loa ding gro ups. 
Mean (+ SEM) insulin-like growth factor-1 concentration in ovine fetal plasma in caloric 
restriction (n = 10), control (n = 10) and caloric loading (n = 6) groups. Hormone concentrations 
are an average for each pair of twins. 
 
6.6 Discussion 
The results of this study show no effect of caloric loading on maternal circulating or placental 
concentration of CNP forms and therefore do not support the hypothesis that CNP production 
by the uteroplacental unit is homeostatically regulated by nutritional status. However, the 
significant increase in maternal circulating NTproCNP concentration during fasting in late 
pregnancy reported here substantiates a previous finding (Prickett et al., 2007) and suggests 
that CNP release into maternal circulation is selectively upregulated by nutrient restriction but 
unaffected by nutrient abundance during pregnancy. 
 
Maternal fasting for three days in late gestation was associated with a 20 % increase in 
maternal circulating NTproCNP concentration; a magnitude of increase similar to that 
reported previously by Prickett et al. (2007). This increase is in direct contrast to the effects of 
caloric restriction in non-pregnant ewes, in which feeding to 25 % of ME requirements is 
associated with a marked decrease in plasma CNP concentration (Prickett et al., 2010c). In the 
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current study, the changes in NTproCNP were accompanied by a marked increase in maternal 
circulating -OHB and urea concentration and a decrease in plasma glucose concentration, 
indicating that a three-day fast represents a significant physiological challenge to the ewe in 
late pregnancy. Surprisingly, and contrary to the original hypothesis, the changes in 
NTproCNP concentration in maternal plasma were not reflected in placental tissues, with no 
difference in protein concentration of either CNP form in the cotyledon evident between CR 
and control ewes. In this study, the number of ewes with everted placentome types (e.g.  
D-type) was too low to allow for comparison of CNP concentration between categories. There 
is evidence to suggest that these more everted placentome types may improve nutrient supply 
to the fetus during periods of undernutrition, and therefore it is possible that differences in 
CNP concentration within this placentome type may exist. However, the functional 
differences between placentome types are likely to be present only if the nutrient restriction is 
present from early pregnancy (Vonnahme et al., 2006). Furthermore, the different placentome 
categories do not differ with respect to vascularity, vasoreactivity or gene expression levels of 
various angiogenic factors (Vonnahme et al., 2008b), suggesting that a difference in CNP 
synthesis/secretion between placentome types is unlikely to explain the increase in maternal 
plasma NTproCNP concentration in CR ewes in the current study. 
 
The absence of an increase in cotyledonary CNP protein concentration in CR ewes does not 
necessarily exclude the BNC as the source of elevated NTproCNP in maternal circulation 
during fasting. The concentration of BNC-derived hormones in placental tissues and maternal 
circulation can be affected by BNC abundance, as well as the rate of migration, maturation, 
fusion and granule release (Wooding et al., 1986; Lea et al., 2007). An increase in the rate of 
granule release, for example, would elevate CNP concentration in maternal circulation with 
no effect on protein concentration within the cotyledon, providing a possible explanation of 
the current results. Elevated maternal circulating oPL concentration has been reported 
following maternal fasting (Brinsmead et al., 1981) and in ewes on low-quality feed during 
pregnancy (Oddy & Jenkin, 1981) suggesting that the BNC is sensitive to nutrient restriction 
and remains a likely source of the elevated NTproCNP in maternal plasma reported here 
during CR. However, as the current study investigated CNP protein concentrations only in 
uterine and placental tissues, extra-placental contributions to maternal circulating CNP forms 
during fasting can not be excluded. Ultrastructural studies of BNC migration and granule 
release, as well as regional sampling of other organs will be required to confirm the BNC as 
the source of the additional CNP in maternal plasma during fasting.  
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Nutrient restriction during pregnancy can have a multitude of effects on maternal, fetal and 
placental tissues, and targeted experiments are required to determine the factor/s responsible 
for stimulating the observed increase in CNP synthesis and/or secretion. A reduction in 
uterine blood flow (UBF) during fasting emerges as a likely candidate, as UBF is extremely 
sensitive to nutrient restriction (Prada et al., 1992) and provides a linkage to the likely role for 
CNP in regulating blood flow during pregnancy (Itoh et al., 1998). UBF may be reduced by 
as much as 43 % during a three-day maternal fast in late pregnancy (Prada et al., 1992), and 
although UBF was not measured in the present study, the significant reduction in fetal weight 
and crown-rump length suggests that reduced UBF was a likely consequence of the caloric 
restriction treatment.  
 
A reduction in UBF during nutrient restriction may be attributable, at least in part, to a 
decrease in fetal and placental NO concentration (Lassala et al., 2010). A relationship 
between CNP and NO in maintaining homeostasis of placental blood flow during fasting is 
plausible, as there is significant cross-talk between the NO and natriuretic peptide systems. 
For example, cGMP, the second messenger produced by binding of CNP to the NPR-B 
receptor, stimulates NO synthesis in VSMCs (Inoue et al., 1995). Furthermore, temporal 
changes in the concentration of NO in maternal circulation during ovine gestation follow a 
similar pattern to that of CNP forms, and likewise NO concentration in maternal plasma has a 
similar positive relationship with fetal number (Vonnahme et al., 2005). A coordinated 
relationship between NO and CNP has been proposed, with a compensatory increase in one 
system occurring if the other is dysfunctional (reviewed by Ahluwalia et al., 2004); providing 
a possible explanation for the increase in CNP, in the face of decreasing NO concentration, 
during fasting. 
 
Clearly, further studies are required to investigate the relationship between UBF, CNP and 
NO both in normal pregnancy and during experimental manipulations to determine whether 
CNP production is affected by changes in UBF. In such experiments, the model used to 
manipulate UBF will be important. For example, the widely-utilised embolism model is 
associated with placental necropsy in addition to reduced UBF (reviewed by Lang et al., 
2000), which could independently affect the production of CNP and NO. Likewise, a 
reduction in UBF is associated with various fetal pathologies, such as hypoxia (McLellan et 
al., 1992) which must also be considered. 
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Although significantly higher than control intake, the daily feed intake of CL ewes during the 
treatment period did not reach the desired level of 200 % of requirements. However, CL ewes 
had significantly higher body condition score at slaughter compared with controls. Body 
condition score in ewes is a reliable marker of energy reserves (Sanson et al., 1993), and 
together with their elevated plasma glucose concentration, indicates that CL ewes were on a 
significantly higher plane of nutrition than control ewes. Furthermore, although there was no 
difference in fetal or placental weight, fetal plasma IGF-1 concentration was elevated in the 
CL group, indicating that the increased nutrient supply in CL ewes was being conferred to the 
fetus. In this study, fetal fat mass and individual organ weights were not recorded and it is 
possible that these measurements may also have revealed differences between the CL and 
control treatments. Of note, there was a trend for a reduction in the number of placentomes in 
CL pregnancies. Placentome number is generally determined in the first trimester of ovine 
pregnancy, and nutritional insult later in gestation is  more likely to be associated with 
changes in placentome size and/or classification (reviewed by Wathes et al., 1998), 
suggesting that the apparent difference in placentome number reported here was not a 
consequence of the nutritional disturbance.  
 
The normal fetal and placental weights reported here following CL treatment are in contrast to 
those reported in the obese pregnant adolescent ewe, a popular model of overfeeding during 
pregnancy. In that model, maternal obesity is associated with hypoxia as well as a significant 
reduction in fetal and placental weight and UBF (reviewed by Reynolds et al., 2005b). These 
adverse pregnancy outcomes have been attributed to enhanced nutrient uptake by the growing 
adolescent mother at the expense of fetal tissues (Redmer et al., 2009). Some of the 
detrimental effects of overfeeding on fetal and placental development in the adolescent sheep 
model have been attributed to a reduction in maternal circulating progesterone concentration 
(Lea et al., 2007; Redmer et al., 2009). An inverse relationship between maternal circulating 
progesterone concentration and feed intake has been reported, probably due to increased 
metabolism as a result of elevated blood flow in the gut and liver (Parr, 1992). In the current 
study, there was no difference in maternal plasma progesterone concentration between CL and 
control ewes at any time-point and this may explain the differences in fetal and placental 
attributes between the current results and those reported previously in the obese adolescent 
model. 
 
In contrast to the popular adolescent model, there are few studies investigating the effect of 
overfeeding in adult ewes. These studies generally report no effect of overfeeding on fetal 
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weight (or lamb birth weight, depending on study design) (Wallace et al., 2005; Muhlhausler 
et al., 2006; current study), despite significant increases in fetal plasma IGF-1, glucose and 
insulin concentration (Wallace et al., 2005; Zhu et al., 2009) and increased fat mass 
(Muhlhausler et al., 2006) in fetuses from overfed dams. Excessive fetal growth can be 
detrimental to maternal and fetal survival at parturition due to dystocia, and thus fetal nutrient 
delivery and growth potential is constrained (reviewed by Gluckman & Pinal, 2003), which 
may explain the absence of a birth weight response in studies of overfeeding during 
pregnancy. Interestingly, in both adolescent and adult models, fetal weight is generally greater 
in overfed animals in mid-pregnancy, but by late-pregnancy is significantly reduced (Redmer 
et al., 2009) or in keeping with that of controls (Ma et al., 2010). This is unlikely to reflect an 
inability of the placenta to meet the demands of these fetuses, or lack of uterine capacity, as 
the combined weight of larger litter sizes illustrates the ability of the uteroplacental unit to 
support a large fetal mass and suggests that some factor/s are in place to constrain the growth 
of individual fetuses.  
 
A reduction in cotyledonary vascularisation and gene expression of a number of angiogenic 
factors has been reported in adult ewes overfed from 60 days pre- until 75 days post-
conception (Zhu et al., 2009; Ma et al., 2010); changes which might be expected to affect 
local production of CNP within the placenta. The absence of a difference in CNP 
concentration in placental tissues from CL ewes compared with controls in the current study 
may be related to the late timing of this nutritional challenge; as it is the periconceptual 
period, targeted in previous studies, that is particularly sensitive to nutritional challenges 
(Bloomfield et al., 2004). Nutritional manipulation in early pregnancy may have a significant 
effect on establishment and development of the placenta. In contrast, the period of caloric 
loading in the current study did not commence until day 95, by which time placental growth is 
complete. 
   
The decrease in fetal plasma concentration of CNP forms reported here during nutrient 
restriction is supported by previous studies in fetal (Prickett et al., 2007) and postnatal 
(Prickett et al., 2005) lambs, and may reflect the apparent cessation of growth in nutrient-
restricted fetuses during the fasting period (Prickett et al., 2005). Fetal circulating cortisol 
concentration increases during maternal undernutrition (reviewed by Gluckman & Pinal, 
2003; Fowden & Forhead, 2004), and may be involved in mediating the reduction in fetal 
plasma concentration of CNP forms during CR (Prickett et al., 2010b). Identification of the 
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sites of production and role of CNP in the fetus will be important for understanding how fetal 
CNP production is regulated, and the possible implications this has for fetal well-being. 
 
In summary, the results of this study firmly establish that there is an increase in maternal 
circulating NTproCNP concentration during fasting in late gestation ewes. Unexpectedly, the 
change in peptide concentration in maternal circulation was not associated with similar 
changes in protein concentration within uterine and placental tissues, possibly reflecting an 
altered rate of granule release from the BNC. There was no effect of caloric loading on the 
concentration of CNP forms in maternal circulation or placental tissues. Collectively these 
findings do not support the hypothesis that CNP production by the uteroplacental unit is 
homeostatically regulated by nutrition, and instead suggest that CNP production is selectively 
upregulated in situations of fetal growth restriction. The stimulus for increased CNP release 
during fasting and the physiological implications of elevated CNP in maternal circulation of 
pregnant ewes remain to be elucidated. 
 
 75
    Chapter 7: 
Effect of mid-pregnancy shearing on maternal 
circulating CNP forms 
 
Declaration 
This study was conducted at Massey University, Palmerston North, New Zealand as part of a 
study led by Dr PR Kenyon investigating the effects of mid-pregnancy shearing on lamb birth 
weight. I travelled to Massey University to assist with blood sampling and weighing ewes, 
and I performed and analysed all of the CNP and NTproCNP assays, but the remainder of the 
experimental work was conducted by Dr Kenyon’s group. Consequently, discussion of the 
results is limited to those which directly relate to CNP.  
 
7.1 Abstract 
Shearing ewes in mid-pregnancy is associated with an increase in lamb birth weight and 
therefore may provide a means of improving productivity and lamb survival. Although the 
mechanism whereby shearing increases lamb birth weight has not been determined, changes 
in placental nutrient transfer capabilities and production of placental hormones have been 
implicated. To investigate a possible involvement of CNP, maternal plasma concentration of 
CNP and NTproCNP was measured at day 69, 75, 95, 110, 125 and 140 in single- and twin-
bearing ewes of Cheviot or Suffolk breed, which were either shorn at day 70 or remained 
unshorn for the duration of pregnancy (n = 7-12 of each birth rank and breed per treatment 
group). Mean individual lamb birth weight was higher in single versus twin lambs (5.9 ± 0.28 
kg vs 5.1 ± 0.15 kg, P < 0.05), and in Suffolk versus Cheviot lambs (6.0 ± 0.23 vs 4.9 ± 0.18 
kg, P < 0.05). Shearing had a positive effect on lamb birth weight in Cheviot (P < 0.05), but 
not Suffolk, lambs (P = NS). There was no effect of shearing on maternal circulating CNP or 
NTproCNP concentration at any stage of pregnancy, regardless of breed or birth rank (P = 
NS). In contrast, maternal circulating concentration of both CNP forms was higher in Cheviot 
compared with Suffolk, and twin- compared with single-bearing ewes at all stages of 
pregnancy (P < 0.05). These data reveal that the relationship between fetal number and 
maternal plasma CNP concentration is already established by the second trimester of ovine 
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pregnancy. The absence of a relationship between CNP and shearing suggests that this peptide 
is unlikely to mediate the increase in fetal growth following shearing. Together with the lack 
of effect of caloric loading (Chapter 6), these findings demonstrate that CNP synthesis and 
secretion during pregnancy are not affected by nutrient abundance.  
7.2 Keywords 
Sheep, mid-pregnancy shearing, CNP, NTproCNP, fetal growth 
7.3 Introduction 
Low birth weight, particularly in litters of two or more lambs, is a common occurrence in 
sheep production. A birth weight outside the optimal range is associated with reduced lamb 
survival and poor performance and is therefore a significant issue for the sheep production 
industry (Gootwine et al., 2007). There is ample evidence from experimental studies that 
shearing ewes in mid-pregnancy is associated with a significant increase in lamb birth weight 
(reviewed by Kenyon et al., 2003), potentially providing a simple and cost-effective means of 
increasing productivity. The beneficial effects of shearing on lamb birth weight are more 
pronounced in twin compared with singleton pregnancies (Corner et al., 2006; Jenkinson et 
al., 2009), suggesting that a response to shearing is possible only if potential lamb growth is 
restricted under normal conditions, as is the case for twin pregnancy (Wu et al., 2006).   
 
Despite a consistent effect of shearing, particularly in twin-bearing ewes, the mechanism/s 
responsible for the increase in lamb birth weight remain unknown, and cannot be attributed to 
an increase in voluntary food intake in response to cold stress in shorn animals (Symonds et 
al., 1986; Revell et al., 2002). Instead, enhanced fetal growth may be the result of changes in 
the production of and/or sensitivity to key nutrients or growth factors including glucose, 
insulin (Symonds et al., 1986), IGF-1 (Jenkinson et al., 2009), fat oxidation pathways 
(Symonds et al., 1989) or thyroid hormones (Symonds et al., 1989). Although placental 
weight does not appear to be affected by shearing (Revell et al., 2002), increased caruncle 
occupancy and higher liver respiration rates in lambs of shorn ewes (Revell et al., 2002) 
suggest that shearing may indirectly promote fetal growth by enhancing utero-placental 
nutrient transfer and placental function. 
 
According to the findings of this thesis, CNP is produced by the fetal trophoblast BNC and 
exported into the maternal system to circulate at very high concentrations during ovine 
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pregnancy (Chapter 5). In addition to likely (but unidentified) endocrine actions in the 
maternal circulation, CNP is likely to have a local vasodilatory role within the placental 
vasculature (Chapter 5, Cameron et al., 1996). Elevated maternal circulating CNP 
concentrations have been reported in situations of fetal growth restriction such as maternal 
fasting (Prickett et al., 2007) and multiple pregnancy (Chapter 4). Furthermore, in humans, 
placental NTproCNP expression is elevated in pre-eclampsia (Prickett et al., 2004), and 
myometrial CNP expression is increased in IUGR (Stepan et al., 2002a). Both of these 
conditions are classified as diseases of the placenta, suggesting that CNP may have a key role 
in regulating placental function and nutrient partitioning to feto-placental tissues. 
 
The aim of the current study was to investigate whether mid-pregnancy shearing is associated 
with changes in CNP production, by measuring maternal circulating CNP forms in mid- to 
late-pregnancy in shorn and unshorn pregnant ewes. As maternal CNP concentration appears 
to be elevated in situations of natural or imposed growth restiction and reduced nutrient 
availability, it is hypothesised, conversely, that maternal plasma CNP concentration will be 
lower in ewes shorn in mid-pregnancy than in their unshorn counterparts. 
7.4 Methods 
7.4.1 Animal procedures 
Mixed-age ewes of Cheviot (n = 118) or Suffolk (n = 99) breed at the Massey University 
Research Farm were used in this study. Animals were run on pasture at Massey University’s 
Tuapaka Farm, 15 km southwest of Palmerston North, New Zealand. Oestrus was 
synchronised in the entire flock by the insertion of CIDRs (‘Eazi-breed’ type G CIDRs, Pfizer 
New Zealand Ltd., Auckland) for 12 days. On the day of CIDR removal (= day 1 of 
pregnancy) the two breeds of ewe were separated and mated with either 6 Cheviot rams 
(Cheviot ewes) or 6 Suffolk rams (Suffolk ewes). Ewes were reunited after removal of rams.  
At day 72 of pregnancy approximately half of the ewes from each breed were shorn using a 
cover comb (Sunbeam New Zealand Ltd, maximum depth of teeth 7-9 mm). All other ewes 
remained unshorn, with approximately 8 months wool growth.  
 
Non-fasting live weight was recorded at day 1, 39, 71, 97, 127 and 142 of pregnancy and then 
at 96 days after the mid-point of the lambing period. Lambs were identified to their dam and 
their sex, weight and birth rank recorded within 12 hours of birth.  
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Blood samples were collected at day 69, 75, 95, 110, 125 and 140 of pregnancy from a 
randomly-selected sub-sample of the flock consisting of approximately equal numbers of 
shorn and unshorn twin- and single-bearing ewes of both breeds for measurement of plasma 
CNP and NTproCNP concentration. Final analyses were performed on data from animals in 
this sub-sample only. The number of animals in each group is summarised in Table 7-1. 
 
Table 7-1. Number of single- a nd twin-bearing C heviot a nd Suffolk ewes in t he two treatment gro ups  (shor n or unshorn) include d for analys is in this st udy . 
Number of single- and twin-bearing Cheviot and Suffolk ewes in the two treatment groups 
(shorn or unshorn) included for analysis in this study. 
 
 
Unshorn Shorn 
Cheviot Single-bearing 10 9 
Twin-bearing 7 7 
Suffolk Single-bearing 7 7 
Twin-bearing 12 9 
 
7.4.2 Statistical analyses 
Statistical analyses were performed using Genstat version 10 (VSN International 
Ltd., Hemel Hempstead, UK). A P value of  0.05 was considered statistically significant. 
Effect of breed, birth rank and shearing treatment on hormone concentration and lamb birth 
weight, and changes in hormone concentration over time within treatments were analysed 
using a REML test and a method of statistical differentials using day of gestation, breed, birth 
rank and shearing treatment as the dependent variables. Relationships between plasma and 
tissue CNP forms and fetal and placental characteristics were examined by fitting the data 
with linear regression best-fit models and testing the deviation from zero slope using an F-
test. Data were log-transformed where appropriate to meet REML assumptions. Data are 
mean and SEM. 
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7.5 Results 
7.5.1 Lamb birth weights 
Mean lamb birth weight was significantly greater in Suffolk (6.0 ± 0.2 kg) compared with 
Cheviot (4.9 ± 0.2 kg) lambs (P < 0.05, Figure 7-1). Total litter weight was greater in twins 
versus singletons (P <0.001), although mean individual lamb birth weight was higher in single 
lambs (5.9 ± 0.3 kg) compared with twins (5.1 ± 0.2 kg) (P < 0.05, Figure 7-1). Mid-
pregnancy shearing had a significant positive effect on lamb birth weight in both twin and 
singleton Cheviot lambs (P < 0.05, Figure 7-1). There was no effect of shearing on lamb birth 
weight in Suffolk lambs of either birth rank (P = NS, Figure 7-1). 
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Figure 7-1. La mb Birth weig ht in singleto n a nd twin la mbs  of Cheviot or Suffolk breed born to ewes which were unshorn for the duratio n of pregna ncy, or shorn in mid-preg nancy. 
Mean (+ SEM) lamb birth weight in (A) singleton and (B) twin lambs of Cheviot or Suffolk 
breed born to ewes which were unshorn for the duration of pregnancy (white bars), or shorn in 
mid-pregnancy (black bars). In the case of twins, lamb birth weight is the combined weight of 
both lambs. The number of animals in each group is indicated on the bars. 
 
7.5.2 Maternal circulating CNP and NTproCNP concentration 
Maternal plasma concentration of CNP forms increased progressively between day 69 and 
day 140 in all groups of ewes, regardless of breed, shearing treatment or birth rank (P < 
0.001). Mid-pregnancy shearing had no effect on maternal circulating CNP or NTproCNP 
concentration at any stage of pregnancy (P = NS, Figure 7-2). There was no interaction 
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between breed and shearing treatment (CNP: P = 0.17; NTproCNP: P = 0.63), indicating that 
the absence of a shearing effect was consistent across the two breeds.  
 
Figure 7-2. Concentratio n of N TproCNP and CNP in materna l circulatio n during pregna ncy in unshor n controls and ewes shorn at day 7 0 of gestatio n.  
Mean (+ SEM) concentration of (A) NTproCNP and (B) CNP in maternal circulation during 
pregnancy in unshorn controls (open circles, n = 36) and ewes shorn at day 70 of gestation 
(closed circles, n = 32). Single- and twin-bearing ewes of both Cheviot and Suffolk breed are 
shown here. 
 
The concentration of both CNP and NTproCNP was elevated in twin- compared with single-
bearing ewes at all time points examined in both breeds (P < 0.001, Figure 7-3). Furthermore, 
there was a significant effect of breed on maternal circulating CNP forms, with higher plasma 
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concentration of both CNP forms in Cheviot versus Suffolk ewes at all time points (P = 0.001, 
Figure 7-3). 
 
 
Figure 7-3. Concentratio n of N TproCNP and CNP in materna l circulatio n during pregna ncy in sing le- and twin- bearing Cheviot and Suffolk ewes. 
Mean (+ SEM) concentration of NTproCNP (A and B) and CNP (C and D) in maternal 
circulation during pregnancy in two breeds of ewe: Suffolk (A and C) and Cheviot (B and D) 
carrying singleton (open circles, Cheviot: n = 19, Suffolk n = 14) or twin (closed circles, Cheviot: 
n = 14, Suffolk n = 21) fetuses. (A) NTproCNP in Suffolk breed; (B) NTproCNP in Cheviot 
breed; (C) CNP in Suffolk breed; (D) CNP in Cheviot breed. A significant difference (P < 0.05) 
in the circulating concentration of CNP forms between singleton and twins is indicated by an *. 
 
7.5.3 Relationship between maternal circulating CNP forms and lamb birth 
weight 
There was some evidence of a modest positive relationship between maternal circulating 
concentration of CNP and lamb birth weight seen only in the twin-lamb cohort. There was no 
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relationship between NTproCNP and lamb birth weight in twins, and no relationship between 
either CNP form and lamb birth weight in singletons (Table 7-2). 
 
Table 7-2. Relationship between maternal  circulating CNP for ms during pregna ncy a nd la mb birth weig ht in singleton and twin preg nanc ies. 
Relationship between maternal circulating CNP forms during pregnancy and lamb birth weight 
in singleton (n = 33) and twin (n = 35) pregnancies. 
 
 
Results of linear regression (r2 and P value) 
 
CNP NTproCNP 
Day of pregnancy Singletons Twins Singletons Twins 
69 ns ns ns ns 
75 ns 0.19, P= 0.01 ns 0.14, P= 0.053 
95 ns 0.13, P = 0.037 0.17, P = 0.02 ns 
110 ns 0.13, P = 0.03 ns ns 
125 ns 0.13, P = 0.037 ns ns 
140 ns 0.19, P = 0.01 ns ns 
 
7.6 Discussion 
In contrast to the original hypothesis, mid-pregnancy shearing was not associated with a 
reduction in the concentration of maternal circulating CNP forms in the current study. This 
result strongly suggests that the effects of shearing on fetal growth are unlikely to involve 
changes in CNP synthesis and/or secretion. The absence of a relationship between maternal 
plasma CNP concentration and shearing treatment, taken with the results of Chapter 6 – in 
which caloric loading did not affect maternal circulating CNP concentration – support the 
hypothesis that CNP secretion into the maternal circulation during ovine pregnancy is not 
homeostatically regulated by fetal nutrient supply.  
The results of the current study, that demonstrate unchanged maternal plasma CNP 
concentration despite a significant increase in lamb birth weight, confirm the finding 
presented in Chapter 6 showing that an increase in fetal nutrient supply had no effect on the 
concentration of CNP forms in the maternal circulation. An increase in maternal plasma 
glucose, and decrease in plasma insulin concentration has been reported in shorn ewes; 
possible reflecting an increase in energy demands by maternal tissues in response to cold-
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stress (Symonds et al., 1986). Consequently, the increase in fetal nutrient supply following 
shearing may simply reflect an increase in glucose transfer across the placenta, as fetal growth 
is directly related to maternal glucose concentration (Schlumbohm & Harmeyer, 2008). This 
increase in nutrient supply may occur without significant changes in placental structure, UBF 
or fetal oxygen supply, providing a possible explanation for the absence of any change in 
maternal plasma CNP concentrations. 
It is noteworthy that higher concentrations of CNP forms were measured in the plasma of 
Cheviot compared with Suffolk ewes in this study. Breed differences in placental 
characteristics have been reported previously in sheep, including placental weight, cotyledon 
number, placentome distribution (proportion of A-, B-, C- and D-type placentomes) and 
placental efficiency (Dwyer et al., 2005). Placental characteristics were not measured in the 
current study, but a previous embryo-transfer study of Cheviot and Suffolk ewes, conducted 
on the same research farm at Massey University, revealed significantly fewer cotyledons in 
placentae from Cheviot ewes (Sharma et al., 2009). Cheviot ewes are smaller and lighter than 
Suffolk ewes, and maternal constraint is therefore inherently greater in this breed (Gluckman 
& Hanson, 2004). This, taken with the lower cotyledon number relative to Suffolk ewes, 
could result in a greater degree of fetal restriction in this breed and may therefore contribute 
to higher maternal circulating CNP concentrations.  
 
A similar embryo transfer study involving Cheviot and Suffolk ewes is currently being 
conducted at Massey University, with plasma samples being collected for analysis of CNP 
forms. It is hypothesised that these samples will show differences in maternal plasma CNP 
concentration between the different treatment groups. Interestingly, Sharma et al. (2009) 
found that birth weight and placentome number of Cheviot lambs in the previous embryo 
transfer study were the same regardless of the breed of the recipient dam. This suggests that 
the Cheviot fetuses are unable to exploit the larger uterine capacity and increased potential for 
nutrient availability provided by the Suffolk host (Sharma et al., 2009). Nonetheless, 
measurement of maternal circulating concentration of CNP forms following embryo transfer 
may provide some insight into the mechanism/s contributing to the breed differences in CNP 
concentrations which occurred in the current study. 
 
In both breeds of sheep a trend for higher circulating CNP forms in twin- versus single-
bearing ewes was already pronounced in the first blood sample collected on day 69 of 
pregnancy. This finding extends the findings reported in Chapter 4 showing a positive 
relationship between maternal circulating CNP forms and fetal number at day 120 of 
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pregnancy to reveal that this difference is already established by mid-pregnancy. The positive 
relationship between maternal plasma CNP concentration and fetal number may reflect an 
increase in total UBF, shear stress or uterine stretch in multiple pregnancies. Maternal 
circulating NO concentration is also positively related to fetal number during ovine pregnancy 
(Vonnahme et al., 2005). It has been proposed that the increase in NO production in multiple 
pregnancy may be mediated by VEGF (Vonnahme et al., 2008a). However, as discussed in 
Chapter 6, it is possible that CNP and NO may constitute a local system of blood-flow 
regulation within the placenta. As there is no relationship between maternal circulating VEGF 
concentration and fetal number (Vonnahme et al., 2005), CNP may be a more likely candidate 
for this communication. 
 
The difference between maternal plasma CNP concentration in single- and twin-bearing ewes 
at all time-points studied suggests that maternal plasma CNP concentration may provide a 
potential index of placental health and development from mid-pregnancy. An understanding 
of the factors regulating placental development has important consequences for postnatal 
development and productivity, as placental function can influence a host of postnatal traits 
including standing and suckling vigour in early life (Dwyer et al., 2005) and future meat 
quality (Jenkinson et al., 1995). The developmental differences between singleton and 
multiple pregnancies also has important consequences for human medicine, due to the 
increased prevalence of multiple pregnancies, which are associated with a high incidence of 
premature birth and other complications (Alexander et al., 1998).  
 
In conclusion, the absence of a reduction in maternal circulating CNP concentration following 
mid-pregnancy shearing suggests that the factor/s mediating increased fetal growth following 
shearing are not key regulators of CNP production during pregnancy. However, the effects of 
breed and fetal number on CNP support the hypothesis that some feature of the growth 
restricted fetus/placenta stimulates CNP production, elucidation of which may provide 
important insight into the peptide’s role in pregnancy. 
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    Chapter 8: 
Final discussion and future direction 
8.1 Major contributions of this thesis 
The findings presented in this thesis contribute significantly to our understanding of CNP’s 
involvement in ruminant pregnancy. Prior to these studies, the temporal changes and source of 
CNP forms in plasma and placental tissues had not been described for any species. 
Consequently, elucidating these parameters in two representative mammalian species were 
important aims of this thesis. The demonstration of a sustained elevation of CNP and 
NTproCNP in maternal plasma and placental tissues during ovine pregnancy provides strong 
evidence to suggest that CNP plays an important role in the hormonal regulation of 
pregnancy. Furthermore, the similarity of the pattern of CNP forms in maternal plasma during 
ovine and cervine pregnancy (Chapter 4) suggests that the peptide’s actions in the pregnant 
female are likely to be conserved among ruminants, and possibly other mammals. 
Another key outcome of the current studies was the immunolocalisation of CNP and 
NTproCNP to the trophoblast BNC (Chapter 5), which strongly implicates these cells as a 
major source of maternal circulating CNP forms during pregnancy. Consequently, the 
previous suggestion that CNP acts primarily as a paracrine/autocrine factor in mammals 
(Walther & Stepan, 2004) must be challenged, based on the established role of the BNC as a 
transporter of fetal products into the maternal circulation. Furthermore, the identification of 
the BNC as a site of CNP production raises the intriguing possibility that CNP may have an 
important role as a feto-maternal communication signal. Although the stimulus for CNP 
production and its effects on maternal function remain to be determined, the results of the 
experiments presented in this thesis support the hypothesis that this communication pathway 
is activated during situations of fetal/placental restriction (possibly of key nutrients and/or 
oxygen), but is unaffected by an increase in fetal nutrient availability.  
In addition to providing novel information regarding aspects of maternal and placental CNP 
biology during pregnancy, these studies extend previous reports of CNP signalling in the 
fetus. Although the role of CNP in fetal development has not been identified, the findings 
reported here – decreasing fetal plasma concentration of CNP forms as gestation progressed – 
do not support a role in fetal bone growth, suggesting distinct roles for the peptide in pre- and 
postnatal life. The novel contributions of this thesis are outlined in Table 8-1. 
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Table 8-1. Summary of novel findings presented in this thes is. 
Summary of novel findings presented in this thesis. 
Documentation of longitudinal profile of maternal circulating concentration of CNP and 
NTproCNP throughout pregnancy in sheep and red deer. 
Identification of a positive relationship between maternal circulating concentration of CNP 
forms and fetal number in ovine pregnancy. 
Localisation of CNP to trophoblast BNCs, suggesting these cells are a probable source of 
CNP forms in the maternal circulation during pregnancy. 
Identification of CNP peaks in fetal cotyledon extracts by size-exclusion HPLC in identical 
positions to those previous identified in maternal plasma, suggesting the CNP forms are 
identical. 
The finding that the concentration of CNP forms in placental tissue exceeds that in uterine 
tissue throughout ovine gestation, with the highest concentrations occurring in the fetal 
cotyledon. 
Documentation of the steady decline in the concentration of CNP forms in fetal plasma 
throughout ovine gestation. 
The demonstration that caloric loading for a two week period during late pregnancy had no 
effect on the concentration of CNP forms in maternal or fetal plasma, or in uteroplacental 
tissues. 
Evidence that the fetal nutrient abundance model of mid-pregnancy shearing has no effect on 
maternal circulating concentration of CNP forms. 
The finding that there are breed-specific differences in maternal circulating concentrations of 
CNP forms in Cheviot and Suffolk ewes during pregnancy. 
 
8.2 CNP’s role in fetal-maternal physiology 
Collectively, the studies described in this thesis provide evidence that CNP has important and 
distinct actions within the caruncle, cotyledon and maternal circulation during pregnancy. 
These findings provide a strong basis for the generation of testable hypotheses to identify and 
distinguish the actions of CNP within these tissues. These are discussed below. 
 
8.2.1.1 Local effects in uterine and placental tissues 
Soon after the discovery of CNP in brain tissue (Sudoh et al., 1990), significant 
concentrations of CNP and NPR-B were identified in the vasculature (reviewed by Woodard 
 88
et al., 2002) and CNP’s actions as a potent vasodilator were confirmed (Itoh et al., 1998). 
Consequently, a role for CNP in regulating vascular tone within the uteroplacental unit and 
mediating the necessary increase in blood flow during pregnancy was proposed (Cameron et 
al., 1996; Itoh et al., 1998). The results of the studies presented here support this hypothesis, 
with the demonstration that changes in the concentration of CNP forms in fetal and maternal 
placental extracts during ovine pregnancy (Chapter 5) are related to the discrete patterns of 
vascular growth and function in the cotyledon and caruncle (reviewed by Reynolds et al., 
2005b). Furthermore, the demonstration of immunolocalisation of CNP forms around 
placental blood vessels suggests involvement in the control of blood flow distribution. 
However, empirical evidence will be required to explore the ideas raised by these 
observational studies and to confirm the role of CNP in maintaining UBF. Possible 
experiments may involve in vitro myographical studies on the direct effects of CNP on 
isolated vessels, which may provide valuable insight into CNP’s effects on specific 
uteroplacental tissues in vivo. Furthermore, measuring UBF and vascular changes (e.g. 
capillary density, vessel diameter, angiogenic factors) following CNP infusion to ewes in 
early gestation, before the commencement of the normal rise in CNP may be revealing. 
During pregnancy, growth and development of uterine and placental tissues is highly 
dependent on the growth of new vessels (reviewed by Reynolds et al., 2005b). In addition to 
promoting vasodilation of existing vessels, CNP may be involved in the development of new 
vessels through its actions as an angiogenic factor (Doi et al., 2001). Capillary area density, a 
marker of angiogenesis (Reynolds et al., 2005b), was not measured in the current studies, but 
would be an informative addition to future studies to determine the involvement of CNP in 
placental angiogenesis. Furthermore, known angiogenic factors could be assayed in specific 
tissues to determine if there is a relationship with CNP concentration. 
In addition to a likely vasoactive role during pregnancy, maintenance of myometrial 
quiescence (discussed in Chapter 5) and immunomodulation at the maternal-fetal interface are 
also possible functions for CNP within the uteroplacental unit. An immunomodulatory role 
for CNP is consistent with its described interactions with various cytokines (Suga et al., 
1993). Furthermore,  as the appearance of BNCs in the fetal trophoblast coincides with 
implantation, BNC-derived factors have been implicated in mediating local immunological 
adaptations which prevent destruction of the conceptus by the maternal immune system 
(Wooding et al., 1992),  
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The placenta is the site of production of numerous hormones and growth factors including 
CNP, and it stands to reason that some of the peptide’s effects may be achieved through 
coordinated interactions with these other factors. Therefore, the identification of these 
interactions may provide important insight into CNP’s function. In this regard, future studies 
investigating a functional relationship between CNP and NO during pregnancy are warranted 
(discussed in Chapter 6). For example, in the pulmonary vasculature, it has been proposed 
that CNP and NO may function as a positive feedback loop (Simon et al., 2009) and a similar 
relationship within the placenta is possible. The proposed compensatory relationship between 
NPs and NO (reviewed by Ahluwalia et al., 2004) has implications for the design and 
interpretation of experimental studies, particularly those which involve blocking the actions of 
CNP, NO or their receptors. VEGF, which has been implicated as a likely mediator of NO-
induced vasodilation during pregnancy (reviewed by Reynolds et al., 2005b) has been shown 
to inhibit CNP secretion in vitro (Doi et al., 1996), and its involvement in a possible feedback 
loop involving CNP and NO may also be worthy of consideration. 
 
8.2.1.2 Endocrine role of CNP in the pregnant female 
Extremely high concentrations of CNP in maternal circulation during ovine pregnancy and 
localisation to the BNC strongly suggest an endocrine mode of action during pregnancy. The 
physiological consequences of the extremely high maternal circulating concentration of CNP 
forms during ruminant pregnancy were not explored in the current studies, and there are very 
few reports in the literature of CNP infusion at concentrations similar to those reported here. 
Therefore, infusion studies using a high titre of CNP forms, to achieve the concentrations 
attained in maternal circulation during ovine pregnancy, should form a key component of 
future studies. In conscious sheep, CNP administration to achieve plasma concentrations of 10 
- 115 pmol l-1 resulted in natriuresis, increased circulating cGMP concentration and a 
dramatic reduction in cardiac output (18 %), suggesting that a hemodynamic role in the 
pregnant female is a possibility (Charles et al., 1995). Administration of CNP to achieve high 
circulating concentrations of the peptide into steroid-primed non-pregnant ewes may be one 
approach to determine CNP’s effects in maternal peripheral tissues. 
Charles et al. (1995) reported no effect of CNP administration on mean arterial blood pressure 
in conscious sheep, a finding that does not support a role for CNP in regulating blood pressure 
during normal pregnancy. However, CNP has a hypotensive effect when administered 
intravenously to rats (Sudoh et al., 1990), and CNP-mediated inhibition of VSMC 
proliferation may prevent increases in peripheral vascular resistance and consequently reduce 
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hypertension (Woodard et al., 2002). Maternal plasma NTproCNP concentration is elevated 
in preeclampsia (Prickett et al., 2004), a condition associated with inappropriately elevated 
blood pressure. These experimental studies suggest a hypotensive role for CNP, with potential 
clinical applications for the peptide to be utilised as an agent to lower maternal blood pressure 
in pathological pregnancies. 
Control of BNC production is believed to be primarily under fetal control, and the effects of 
BNC-derived products in the maternal circulation therefore may be expected to promote 
nutrient transfer for the benefit of the fetus. For example, oPL is believed to enhance fetal 
nutrient supply directly by facilitating glucose transfer from mother to fetus (reviewed by 
Gootwine, 2004). Other BNC products may enhance fetal nutrient supply indirectly, for 
example by increasing blood flow (reviewed by Fowden et al., 2006). A comparable indirect 
role for CNP in promoting fetal growth via increased UBF is likely, but direct roles, such as 
promoting lipolysis from maternal fat cells are also possible, as suggested by recent studies in 
humans (Lafontan & Langin, 2009).  
The amino acid sequence of CNP-22 is highly conserved amongst vertebrate species, which 
suggests that its function also is highly conserved. Therefore, examination of CNP’s role in 
phylogenetically ancient species may provide important insight for understanding its function 
in mammalian pregnancy. For example, an endocrine role for CNP has been proposed in the 
Japanese eel (Anguilla japonica) due to the high circulating concentrations of the peptide 
following transition from a saltwater to freshwater environment (Takei et al., 2001). This 
phenomenon suggests a possible role for CNP in osmoregulation which also may be 
operational in other vertebrate groups. 
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8.3 Conceptual model 
A conceptual model to describe the control of CNP production during ruminant pregnancy is 
proposed in Figure 8-1 using the novel findings of this thesis together with data from the 
literature. 
 
Figure 8-1. Propo sed co nceptual  model show ing CNP’s actio ns during ruminant pregna ncy. 
Proposed conceptual model showing CNP’s actions during ruminant pregnancy. Pathways 
highlighted with bold arrows are predicted to be upregulated during nutrient restriction (e.g. 
maternal fasting, multiple fetuses). 
 
8.4 Implications 
The current studies, in showing high concentrations of CNP in pregnant ruminants, identify 
CNP as an important new hormone of pregnancy. Furthermore, the novel finding that CNP 
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production is upregulated in situations of fetal restriction raises the possibility that CNP may 
be a marker of fetal and/or placental development and wellbeing. This potentially has 
applications for human medicine and animal production. 
Clearly, elucidation of CNP’s function in the pregnant female will be necessary to determine 
its potential suitability as a marker of wellbeing. Although the current RIA protocol used to 
determine CNP concentration provides results with very high sensitivity, the long duration of 
the assay (at least 4 days from sample collection to assay completion), requirement for highly 
specialised equipment and skilled personnel, high cost per sample and reliance on radioactive 
isotopes makes the assay unsuitable for use outside of a laboratory and consequently is of 
limited relevance in a field situation. Furthermore, the CNP assay currently requires collection 
of relatively large sample volumes, which must be continuously chilled and promptly 
centrifuged due to the labile nature of the peptide. Therefore, these issues will need to be 
addressed before CNP can be utilised as a routine diagnostic test in large-scale animal 
production systems. Despite these technical limitations, measurement of CNP concentrations 
during pregnancy may contribute significantly to effective animal production systems. In 
particular, the ability accurately to determine fetal number early in pregnancy would be 
particularly advantageous; suggesting that development of new, simple and cost-effective 
assays for CNP forms may be worthwhile. In this context, as circulating levels are very high 
during pregnancy the development of a rapid 15 minute analyser similar to the NTproBNP 
bedside test unit is feasible. 
 
In light of the current studies on ruminants, and the potential clinical applications arising from 
these studies, the role of CNP in human pregnancy must now be readdressed. There have been 
relatively few studies investigating CNP’s involvement in human pregnancy, and typically 
these have included low numbers of study participants, limited sampling frequency, cross-
sectional design and analysis of CNP only, with no measurement of NTproCNP. The subtle 
changes reported in circulating maternal CNP concentration during cervine pregnancy despite 
dramatic changes in NTproCNP (Chapter 4) clearly illustrates the value of utilising 
NTproCNP concentration as a marker of CNP activity, in addition to CNP itself, and 
demonstrates the advantages of a longitudinal study over a cross-sectional design. With robust 
assay techniques for measuring NTproCNP now available, it will be important in future work 
to conduct similar studies in pregnant women to understand whether the changes that occur in 
ruminants are also a feature of human pregnancy. Further, although it is generally assumed 
that NTproCNP is biologically-inactive, the extremely high concentrations of NTproCNP 
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reported here during pregnancy require that this assumption must be confirmed equivocally 
experimentally to exclude a possible independent role for NTproCNP.  
The finding of a marked decline in maternal plasma concentration of both CNP forms in the 
final week of ruminant pregnancy implicates the peptide as a possible marker of impending 
parturition. Consequently, future studies involving a more intense sampling regime to provide 
a detailed description of the changes in CNP production which occur in the final stages of 
pregnancy will be important. In humans, premature birth is a significant cause of neonatal 
morbidity and mortality and is associated with numerous developmental and physiological 
consequences which may persist into adulthood. Presently, the difficulty in predicting and 
therefore preventing premature birth is a significant challenge in clinical medicine (reviewed 
by Moss, 2005), further highlighting the need for new studies to characterise comprehensively 
the role of CNP in human pregnancy.  
The role, if any, of maternal and fetal cortisol concentration in regulating CNP production 
during pregnancy remains unresolved. Despite the temporal association between the decline 
in maternal circulating CNP forms and the prepartum fetal cortisol surge, both low (Prickett et 
al., 2010a) and high (our unpublished pilot study) doses of cortisol administered to ovine 
fetuses appeared to have no effect on maternal circulating CNP concentration. Experimental 
studies in sheep have shown that the normal decline in BNC in the final week of pregnancy 
can be prevented by fetal hypophysectomy (Wooding et al., 1986) or adrenalectomy and 
induced prematurely by fetal (Ward et al., 2002) or maternal (Braun et al., 2007) 
glucocorticoid administration, suggesting that a possible role for cortisol in regulating 
maternal CNP production may warrant further investigation.  
Since the pivotal reports of Barker and the development of the early origins of health and 
disease hypothesis (De Boo & Harding, 2006; Barker, 2007), there has been increasing 
evidence to support the idea that an individual’s experiences before birth have a significant 
impact on future health and well-being, both in their own lifetime and also during that of their 
offspring. Consequently, the relationship between CNP and feto-placental development has 
relevance both for adult health in humans and future productivity in production animals. 
Recently, there has been a considerable focus on identifying factors involved in promoting 
UBF and angiogenesis for use as therapeutic agents in preventing and treating IUGR in 
compromised pregnancies (Reynolds et al., 2010). The studies presented in this thesis provide 
important new evidence to implicate CNP as a novel candidate for such an agent. There is 
now an urgent requirement to identify the function/s of CNP within the placenta and maternal 
circulation, and to characterise fully the factor/s regulating its synthesis and secretion in order 
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to exploit the potential therapeutic benefits of this peptide for both human health and animal 
production. 
  
 95
References 
 
Acuff, C, Huang, H, & Steinhelper, M. (1997). Estradiol induces C-type natriuretic peptide 
gene expression in mouse uterus. American Journal of Physiology, 273, H2672-
H2677. 
Agoston, H, Baybayan, L, & Beier, F. (2006). Dexamethasone stimulates expression of C-
type natriuretic peptide in chondrocytes. BMC Musculoskeletal Disorders, 7, 87-93. 
Ahluwalia, A, & Hobbs, AJ. (2005). Endothelium-derived C-type natriuretic peptide: more 
than just a hyperpolarizing factor. Trends in Pharmacological Sciences, 26, 162-167. 
Ahluwalia, A, MacAllister, R, & Hobbs, A. (2004). Vascular actions of natriuretic peptides. 
Basic Research in Cardiology, 99, 83-89. 
Alexander, GR, Kogan, M, Martin, J, & Papiernik, E. (1998). What are the fetal growth 
patterns of singletons, twins, and triplets in the United States? Clinical Obstetrics and 
Gynecology, 41, 114-125. 
Anand-Srivastava, MB. (2005). Natriuretic peptide receptor-C signaling and regulation. 
Peptides, 26, 1044-1059. 
Anderson, GM, & Barrell, GK. (1998). Effects of thyroidectomy and thyroxine replacement 
on seasonal reproduction in the red deer hind. Journal of Reproduction and Fertility, 
113, 239-250. 
Barbera, A, Jone, O, Zerbe, G, Hobbins, J, Battaglia, F, & Meschia, G. (1995). 
Ultrasonographic assessment of fetal growth: comparison between human and ovine 
fetus. American Journal of Obstetrics and Gynecology, 173, 1765-1769. 
Barker, DJP. (2007). The origins of the developmental origins theory. Journal of Internal 
Medicine, 261, 412-417. 
 96
Barnes, RJ, Comline, RS, & Silver, M. (1978). Effect of cortisol on liver glycogen 
concentrations in hypophysectomized, adrenalectomized and normal foetal lambs 
during late or prolonged gestation. Journal of Physiology, 275, 567-579. 
Barry, JS, & Anthony, RV. (2008). The pregnant sheep as a model for human pregnancy. 
Theriogenology, 69, 55-67. 
Bartels, C, Bukulmez, H, Padayatti, P, Rhee, D, van Ravenswaaij-Arts, C, Pauli, R, Mundlos, 
S, Chitayat, D, Shih, L, Al-Gazali, L, Kant, S, Cole, T, Morton, J, Cormier-Daire, V, 
Faivre, L, Lees, M, Kirk, J, Mortier, G, Leroy, J, Zabel, B, Kim, C, Crow, Y, 
Braverman, N, van den Akker, F, & Warman, M. (2004). Mutations in the 
transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause 
acromesomelic dysplasia, type Maroteaux. American Journal of Human Genetics, 75, 
27-34. 
Bell, A, Ferrell, C, & Freetly, H. (2005). Pregnancy and fetal metabolism. In J Dijkstra, J 
Forbes & J France (Eds.), Quantitative aspects of ruminant digestion and metabolism 
(5 ed., pp. 523-550). Oxfordshire: CABI Publishing. 
Blackburn, DG. (Ed.) (1999) Encyclopedia of reproduction (Vol. 4). New York: Academic 
Press. 
Bloomfield, F, Oliver, M, Hawkins, P, Holloway, A, Campbell, M, Gluckman, PD, Harding, 
J, & Challis, JRG. (2004). Periconceptional undernutrition in sheep accelerates 
maturation of the fetal hypothalamic-pituitary-adrenal axis in late gestation. 
Endocrinology, 145, 4278-4285. 
Bocciardi, R, Giorda, R, Buttgereit, J, Gimelli, S, Divizia, MT, Beri, S, Garofalo, S, Tavella, 
S, Lerone, M, Zuffardi, O, Bader, M, Ravazzolo, R, & Gimelli, G. (2007). 
Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth 
and bone anomalies in an individual with balanced t(2;7) translocation. Human 
Mutation, 28, 724-731. 
Braun, T, Li, S, Moss, TJM, Newnham, JP, Challis, JRG, Gluckman, PD, & Sloboda, DM. 
(2007). Maternal betamethasone administration reduces binucleate cell number and 
placental lactogen in sheep. Journal of Endocrinology, 194, 337-347. 
 97
Brinsmead, M, Bancroft, B, Thorburn, G, & Waters, M. (1981). Fetal and maternal ovine 
placental lactogen during hyperglycaemia, hypoglycaemia, and fasting. Journal of 
Endocrinology, 90, 337. 
Byatt, J, Warren, W, Eppard, P, Staten, N, Krivi, G, & Collier, R. (1992). Ruminant placental 
lactogens: structure and biology. Journal of Animal Science, 70, 2911-2923. 
Cameron, VA, Aitken, GD, Ellmers, LJ, Kennedy, MA, & Espiner, EA. (1996). The sites of 
gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal 
development: temporal changes in embryos and placenta. Endocrinology, 137, 817-
824. 
Carnegie, JA, & Robertson, HA. (1978). Conjugated and unconjugated estrogens in fetal and 
maternal fluids of the pregnant ewe: A possible role for estrone sulfate during early 
pregnancy. Biology of Reproduction, 19, 202-211. 
Carvajal, JA, Delpiano, AM, Cuello, MA, Poblete, JA, Casanello, PC, Sobrevia, LA, & 
Weiner, CP. (2009). Brain natriuretic peptide (BNP) produced by the human 
chorioamnion may mediate pregnancy myometrial quiescence. Reproductive Sciences, 
16, 32-42. 
Chan, JS, Robertson, HA, & Friesen, HG. (1978). Maternal and fetal concentrations of ovine 
placental lactogen measured by radioimmunoassay. Endocrinology, 102, 1606-1613. 
Charles, C, Espiner, EA, Richards, A, Nicholls, M, & Yandle, T. (1995). Biological actions 
and pharmacokinetics of C-type natriuretic peptide in conscious sheep. American 
Journal of Physiology, 268, R201-R207. 
Charles, C, Espiner, EA, Richards, A, Nicholls, M, & Yandle, T. (1996). Comparative 
bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep. 
American Journal of Physiology, 270, R1324-R1331. 
Charles, C, Prickett, T, Espiner, EA, Rademaker, M, Richards, A, & Yandle, T. (2006). 
Regional sampling and the effects of experimental heart failure in sheep: Differential 
responses in A, B and C-type natriuretic peptides. Peptides, 27, 62-68. 
 98
Chauhan, SD, Nilsson, H, Ahluwalia, A, & Hobbs, AJ. (2003). Release of C-type natriuretic 
peptide accounts for the biological activity of endothelium-derived hyperpolarizing 
factor. Proceedings of the National Academy of Sciences of the United States of 
America, 100, 1426-1431. 
Cheung, C, Gibbs, DM, & Brace, R. (1987). Atrial natriuretic factor in maternal and fetal 
sheep. American Journal of Physiology, 252, E279-E282. 
Chun, TH, Itoh, H, Ogawa, Y, Tamura, N, Takaya, K, Igaki, T, Yamashita, J, Doi, K, Inoue, 
M, Masatsugu, K, Korenaga, R, Ando, J, & Nakao, K. (1997). Shear stress augments 
expression of C-type natriuretic peptide and adrenomedullin. Hypertension, 29, 1296-
1302. 
Chusho, H, Tamura, N, Ogawa, Y, Yasoda, A, Suda, M, Miyazawa, T, Nakamura, K, Nakao, 
K, Kurihara, T, Komatsu, Y, Itoh, H, Tanaka, K, Saito, Y, Katsuki, M, & Nakao, K. 
(2001). Dwarfism and early death in mice lacking C-type natriuretic peptide. 
Proceedings of the National Academy of Sciences of the United States of America, 98, 
4016-4021. 
Corner, RA, Kenyon, PR, Stafford, JK, West, DM, & Oliver, MH. (2006). The effect of mid-
pregnancy shearing or yarding stress on ewe post-natal behaviour and the birth weight 
and post-natal behaviour of their lambs. Livestock Science, 102, 121-129. 
de Bold, AJ, Borenstein, HB, Veress, AT, & Sonnenberg, H. (1981). A rapid and potent 
natriuretic response to intravenous injection of atrial myocardial extract in rats. Life 
Sciences, 28, 89-94. 
De Boo, H, & Harding, J. (2006). The developmental origins of adult disease (Barker) 
hypothesis. Australian and New Zealand Journal of Obstetrics and Gynaecology, 46, 
4-14. 
DiCicco-Bloom, E, Lelièvre, V, Zhou, X, Rodriguez, W, Tam, J, & Waschek, JA. (2004). 
Embryonic expression and multifunctional actions of the natriuretic peptides and 
receptors in the developing nervous system. Developmental Biology, 271, 161-175. 
 99
DiFederico, E, Genbacev, O, & Fisher, S. (1999). Preeclampsia is associated with widespread 
apoptosis of placental cytotrophoblasts within the uterine wall. American Journal of 
Pathology, 155, 293-301. 
Doi, K, Ikeda, T, Itoh, H, Ueyama, K, Hosoda, K, Ogawa, Y, Yamashita, J, Chun, T-H, 
Inoue, M, Masatsugu, K, Sawada, N, Fukunaga, Y, Saito, T, Sone, M, Yamahara, K, 
Kook, H, Komeda, M, Ueda, M, & Nakao, K. (2001). C-Type natriuretic peptide 
induces redifferentiation of vascular smooth muscle cells with accelerated 
reendothelialization. Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 930-
936. 
Doi, K, Itoh, H, Komatsu, Y, Igaki, T, Chun, T-H, Takaya, K, Yamashita, J, Inoue, M, 
Yoshimasa, T, & Nakao, K. (1996). Vascular endothelial growth factor suppresses C-
type natriuretic peptide secretion. Hypertension, 27, 811-815. 
Doi, K, Itoh, H, Nakagawa, O, Igaki, T, Yamashita, J, Chun, T, Inoue, M, Masatsugu, K, & 
Nakao, K. (1997). Expression of natriuretic peptide system during embryonic stem 
cell vasculogenesis. Heart Vessels, Supplement 12, 18-22. 
Dwyer, CM, Calvert, SK, Farish, M, Donbavand, J, & Pickup, HE. (2005). Breed, litter and 
parity effects on placental weight and placentome number, and consequences for the 
neonatal behaviour of the lamb. Theriogenology, 63, 1092-1110. 
Ehrhardt, R, & Bell, A. (1995). Growth and metabolism of the ovine placenta during mid-
gestation. Placenta, 16, 727-741. 
Espiner, EA, Prickett, T, Barrell, G, Yandle, T, Rumball, C, & Harding, J. (2008). Emerging 
roles for CNP. Endocrine Abstracts, 15, S32. 
Espiner, EA, Prickett, T, Yandle, T, Barrell, G, Wellby, M, Sullivan, M, & Darlow, B. (2007). 
ABCs of natriuretic peptides: growth. Hormone research, 67 (supplement), 81-90. 
Etchernkamp, S, Vonnahme, KA, Green, JA, & Ford, SP. (2006). Increased vascular 
endothelial growth factor and pregnancy-associated glycoproteins, but not insulin-like 
growth factor-1, in maternal blood of cows gestating twin fetuses. Journal of Animal 
Science, 84, 2057-2064. 
 100
Ferrell, C, & Reynolds, LP. (1992). Uterine and umbilical blood flows and net nutrient uptake 
by fetuses and uteroplacental tissues of cows gravid with either single or twin fetuses. 
Journal of Animal Science, 70, 426-433. 
Fowden, AL, & Forhead, AJ. (2004). Endocrine mechanisms of intrauterine programming. 
Reproduction, 127, 515-526. 
Fowden, AL, Sferruzzi-Perri, AN, Coan, PM, Constancia, M, & Burton, GJ. (2009). Placental 
efficiency and adaptation: endocrine regulation. The Journal of Physiology, 587, 3459-
3472. 
Fowden, AL, Ward, JW, Wooding, FBP, Forhead, AJ, & Constancia, M. (2006). 
Programming placental nutrient transport capacity. Journal of Physiology, 572, 5-15. 
Franz, MB, Andreas, M, Schiessl, B, Zeisler, H, Neubauer, A, Kastl, SP, Hess, G, Rhomberg, 
F, Zdunek, D, Maurer, G, Schlembach, D, Heinze, G, Szekeres, T, & Gottsauner-
Wolf, M. (2009). NT-proBNP is increased in healthy pregnancies compared to non-
pregnant controls. Acta Obstetricia et Gynecologica Scandinavica, 88, 234-237. 
Furuya, M, Yoshida, M, Hayashi, Y, Ohnuma, N, Minamino, N, Kangawa, K, & Matsuo, H. 
(1991). C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle 
cells. Biochemical and Biophysical Research Communications, 177, 927-931. 
Gluckman, PD, & Hanson, MA. (2004). Maternal constraint of fetal growth and its 
consequences. Seminars in Fetal and Neonatal Medicine, 9, 419-425. 
Gluckman, PD, & Pinal, CS. (2003). Regulation of fetal growth by the somatotrophic axis. 
Journal of Nutrition, 133, 1741S-1746S. 
Gootwine, E. (2004). Placental hormones and fetal-placental development. Animal 
Reproduction Science, 82-83, 551-566. 
Gootwine, E, Spencer, TE, & Bazer, FW. (2007). Litter-size-dependent intrauterine growth 
restriction in sheep. Animal, 1, 547-564. 
 101
Hameed, AB, Chan, K, Ghamsary, M, & Elkayam, U. (2009). Longitudinal changes in the B-
type natriuretic peptide levels in normal pregnancy and postpartum. Clinical 
Cardiology, 32, E60-E62. 
Handwerger, S, Maurer, WF, Crenshaw, MC, Hurley, T, Barrett, J, & Fellows, RE. (1975). 
Development of the sheep as an animal model to study placental lactogen physiology. 
The Journal of Pediatrics, 87, 1139-1143. 
Hunt, PJ, Richards, AM, Espiner, EA, Nicholls, MG, & Yandle, TG. (1994). Bioactivity and 
metabolism of C-type natriuretic peptide in normal man. Journal of Clinical 
Endocrinology and Metabolism, 78, 1428-1435. 
Inoue, K, Naruse, K, Yamagami, S, Mitani, H, Suzuki, N, & Takei, Y. (2003). Four 
functionally distinct C-type natriuretic peptides found in fish reveal evolutionary 
history of the natriuretic peptide system. Proceedings of the National Academy of 
Sciences of the United States of America, 100, 10079-10084. 
Inoue, T, Fukuo, K, Nakahashi, T, Hata, S, Morimoto, S, & Ogihara, T. (1995). cGMP 
upregulates nitric oxide synthase expression in vascular smooth muscle cells. 
Hypertension, 25, 711-714. 
Itoh, H, Bird, IM, Nakao, K, & Magness, RR. (1998). Pregnancy increases soluble and 
particulate guanylate cyclases and decreases the clearance receptor of natriuretic 
peptides in ovine uterine, but not systemic, arteries. Endocrinology, 139, 3329-3341. 
Itoh, H, Sagawa, N, Matsumoto, T, Fujii, S, Nakao, K, Bird, IM, & Magness, RR. (1999). 
Role of the guanylate cyclase system in the regulation of ovine uterine arterial blood 
flow during pregnancy. Trophoblast Research, 13, 301-309. 
Jankowski, M, Reis, AM, Mukaddam-Daher, S, Dam, TV, Farookhi, R, & Gutkowska, J. 
(1997). C-type natriuretic peptide and the guanylyl cyclase receptors in the rat ovary 
are modulated by the estrous cycle. Biology of Reproduction, 56, 59-66. 
  
 102
Jenkinson, CM, Kenyon, PR, Blair, HT, Breier, BH, & Gluckman, PD. (2009). Birth weight 
effect in twin-born lambs from mid-pregnancy shearing is associated with changes in 
maternal IGF-1 concentration. New Zealand Journal of Agricultural Research, 52, 
261-268. 
Jenkinson, CMC, Peterson, SW, Mackenzie, DDS, McDonald, MF, & McCutcheon, SN. 
(1995). Seasonal effects on birth weight in sheep are associated with changes in 
placental development. New Zealand Journal of Agricultural Research, 38, 337-345. 
Johnson, MH. (2007). Essential reproduction (6th ed.). Oxford: Blackwell Publishing. 
Kalra, PR, Anker, SD, Struthers, AD, & Coats, AJS. (2001). The role of C-type natriuretic 
peptide in cardiovascular medicine. European Heart Journal, 22, 997-1007. 
Kappes, SM, Warren, WC, Pratt, SL, Liang, R, & Anthony, RV. (1992). Quantification and 
cellular localization of ovine placental lactogen messenger ribonucleic acid expression 
during mid- and late gestation. Endocrinology, 131, 2829-2838. 
Kawakoshi, A, Hyodo, S, Inoue, K, Kobayashi, Y, & Takei, Y. (2004). Four natriuretic 
peptides (ANP, BNP, VNP and CNP) coexist in the sturgeon: identification of BNP in 
fish lineage. Journal of Molecular Endocrinology, 32, 547-555. 
Kenyon, PR, Morris, ST, Revell, DK, & McCutcheon, SN. (2003). Shearing during 
pregnancy - review of a policy to increase brithweight and survival of lambs in New 
Zealand pasotral farming systems. New Zealand Veterinary Journal, 51, 200-207. 
Kikkawa, F, Kajiyama, H, Ino, K, Watanabe, Y, Ito, M, Nomura, S, Itakura, A, Tsujimoto, M, 
& Mizutani, S. (2002). Possible involvement of placental peptidases that degrade 
gonadotropin-releasing hormone (GnRH) in the dynamic pattern of placental hCG 
secretion via GnRH degradation. Placenta, 23, 483-489. 
  
 103
Komatsu, Y, Chusho, H, Tamura, N, Yasoda, A, Miyazawa, T, Suda, M, Miura, M, Ogawa, 
Y, & Nakao, K. (2002). Significance of C-type natriuretic peptide (CNP) in 
endochondral ossfication: analysis of CNP knockout mice. Journal of Bone and 
Mineral Metabolism, 20, 331-336. 
Lafontan, M, & Langin, D. (2009). Lipolysis and lipid mobilization in human adipose tissue. 
Progress in Lipid Research, 48, 275-297. 
Lang, U, Baker, RS, Khoury, J, & Clark, KE. (2000). Effects of chronic reduction in uterine 
blood flow on fetal and placental growth in the sheep. American Journal of 
Physiology, 279, R53-59. 
Lassala, A, Bazer, FW, Cudd, TA, Datta, S, Keisler, DH, Satterfield, MC, Spencer, TE, & 
Wu, G. (2010). Parenteral administration of L-arginine prevents fetal growth 
restriction in undernourished ewes. Journal of Nutrition, 140, 1242-1248. 
Lea, RG, Wooding, P, Stewart, I, Hannah, LT, Morton, S, Wallace, K, Aitken, RP, Milne, JS, 
Regnault, TR, Anthony, RV, & Wallace, JM. (2007). The expression of ovine 
placental lactogen, StAR and progesterone-associated steroidogenic enzymes in 
placentae of overnourished growing adolescent ewes. Reproduction, 133, 785-796. 
Lee, C, Wooding, FB, & Morgan, G. (1995). Quantitative analysis of intraepithelial large 
granular lymphocyte distribution and maternofetal cellular interactions in the 
synepitheliochorial placenta of the deer. Journal of Anatomy, 187, 445-460. 
Lubbers, WC, & Eghtesady, P. (2007). Fetal aortic stenosis and changes in amniotic fluid 
natriuretic peptides. American Journal of Obstetrics and Gynecology, 196, 253.e251-
253.e256. 
Ma, Y, Zhu, MJ, Zhang, L, Hein, SM, Nathanielsz, PW, & Ford, SP. (2010). Maternal obesity 
and overnutrition alters fetal growth rate and cotyledonary vascularity and angiogenic 
factor expression in the ewe. American Journal of Physiology, 299, 249-258. 
Madhani, M, Scotland, R, MacAllister, RJ, & Hobbs, A. (2003). Vascular natriuretic peptide 
receptor-linked particulate guanylate cyclases are modulated by nitric oxide–cyclic 
GMP signalling. British Journal of Pharmacology, 139, 1289-1296. 
 104
McArdle, CA, Olcese, J, Schmidt, C, Poch, A, Kratzmeier, M, & Middendorff, R. (1994). C-
type natriuretic peptide (CNP) in the pituitary: is CNP an autocrine regulator of 
gonadotropes? Endocrinology, 135, 2794-2801. 
McArdle, CA, Poch, A, & Kappler, K. (1993). Cyclic guanosine monophosphate production 
in the pituitary: stimulation by C-type natriuretic peptide and inhibition by 
gonadotropin-releasing hormone in alpha T3-1 cells. Endocrinology, 132, 2065-2072. 
McLellan, KC, Hooper, SB, Bocking, AD, Delhanty, PJ, Phillips, ID, Hill, DJ, & Han, VK. 
(1992). Prolonged hypoxia induced by the reduction of maternal uterine blood flow 
alters insulin-like growth factor-binding protein-1 (IGFBP-1) and IGFBP-2 gene 
expression in the ovine fetus. Endocrinology, 131, 1619-1628. 
McNeill, BA, Barrell, GK, Wellby, M, Prickett, TCR, Yandle, TG, & Espiner, EA. (2009a). 
C-type natriuretic peptide (CNP) forms in pregnancy: maternal plasma profiles during 
ovine gestation correlate with placental and fetal maturation. Endocrinology, 150, 
4777-4783. 
McNeill, BA, Prickett, TCR, Wellby, M, Ridgway, MJ, Espiner, EA, & Barrell, GK. (2010). 
Circulating levels of C-type natriuretic peptide (CNP) are strongly linked to pregnancy 
but not to liveweight changes in ruminants. Proceedings of the New Zealand Society of 
Animal Production, 70, 13-18. 
McNeill, BA, Wellby, M, Prickett, TCR, Harding, J, Yandle, TG, Espiner, EA, & Barrell, 
GK. (2009b). The placenta is a major site of CNP synthesis during ovine pregnancy: 
Differential contributions to maternal and fetal circulations. Program of the 91st 
annual meeting of the Endocrine Society, Washington, DC. 
Moncla, A, Missirian, C, Cacciagli, P, Balzamo, E, Legeai-Mallet, L, Jouve, JL, Chabrol, B, 
Le Merrer, M, Plessis, G, Villard, L, & Philip, N. (2007). A cluster of translocation 
breakpoints in 2q37 is associated with overexpression of NPPC in patients with a 
similar overgrowth phenotype. Human Mutation, 28, 1183-1188. 
Moss, TJ. (2005). The respiratory consequences of preterm birth. Proceedings of the 
Australian Physiological Society, 36, 23-28. 
 105
Muhlhausler, BS, Adam, CL, Findlay, PA, Duffield, JA, & McMillen, IC. (2006). Increased 
maternal nutrition alters development of the appetite-regulating network in the brain. 
FASEB Journal, 20, 1257-1259. 
Müller, D, Hida, B, Guidone, G, Speth, RC, Michurina, TV, Enikolopov, G, & Middendorff, 
R. (2009). Expression of guanylyl cyclase (GC)-A and GC-B during brain 
development: evidence for a role of GC-B in perinatal neurogenesis. Endocrinology, 
150, 5520-5529. 
Nicol, AM, & Brookes, IM. (2007). The metabolisable energy requirements of grazing 
livestock. In PV Rattray, IM Brookes & AM Nicol (Eds.), Pasture and supplements 
for grazing animals (Vol. 14, pp. 151-172). Hamilton: New Zealand Society of 
Animal Production Occasional Publication. 
Oddy, VH, & Jenkin, G. (1981). Diet and fetal number influence ovine placental lactogen 
concentration. Proceedings of the Nutrition Society of Australia, 6, 151. 
Okahara, K, Kambayashi, J-i, Ohnishi, T, Fujiwara, Y, Kawasaki, T, & Monden, M. (1995). 
Shear stress induces expression of CNP gene in human endothelial cells. FEBS 
Letters, 373, 108-110. 
Olney, RC, Bukulmez, H, Bartels, CF, Prickett, TCR, Espiner, EA, Potter, LR, & Warman, 
ML. (2006). Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are 
associated with short stature. Journal of Clinical Endocrinology and Metabolism, 91, 
1229-1232. 
Parr, RA. (1992). Nutrition-progesterone interactions during early pregnancy in sheep. 
Reproduction Fertility and Development, 4, 297-300. 
Pemberton, CJ, Yandle, TG, Rademaker, MT, Charles, CJ, Aitken, GD, & Espiner, EA. 
(1998). Amino-terminal proBNP in ovine plasma: evidence for enhanced secretion in 
response to cardiac overload. American Journal of Physiology, 275, H1200-1208. 
Podjarny, E, Baylis, C, & Losonczy, G. (1999). Animal models of preeclampsia. Seminars in 
Perinatology, 23, 2-13. 
 106
Potter, LR, Abbey-Hosch, S, & Dickey, DM. (2006). Natriuretic peptides, their receptors, and 
cyclic guanosine monophosphate-dependent signaling functions. Endocrine Reviews, 
27, 47-72. 
Prada, JA, Ross, R, & Clark, KE. (1992). Hypocalcemia and pregnancy-induced hypertension 
produced by maternal fasting. Hypertension, 20, 620-626. 
Prickett, T, Dixon, B, Frampton, C, Yandle, T, Richards, A, Espiner, EA, & Darlow, B. 
(2008a). Plasma amino-terminal pro C-type natriuretic peptide in the neonate: relation 
to gestational age and postnatal linear growth. Journal of Clinical Endocrinology and 
Metabolism, 93, 225-232. 
Prickett, T, Kaaja, R, Nicholls, M, Espiner, E, Richards, A, & Yandle, T. (2004). N-terminal 
pro-C-type natriuretic peptide, but not C-type natriuretic peptide, is greatly elevated in 
the fetal circulation. Clinical Science, 106, 535-540. 
Prickett, T, Lynn, A, Barrell, G, Darlow, B, Cameron, V, Espiner, E, Richards, A, & Yandle, 
T. (2005). Amino-terminal proCNP: a putative marker of cartilage activity in postnatal 
growth. Pediatric Research, 58, 334-340. 
Prickett, T, Yandle, T, Barrell, G, Wellby, M, Nicholls, M, Espiner, EA, & Richards, A. 
(2003). Identification of amino-terminal pro-C-type natriuretic peptide in human, 
sheep and deer plasma (Abstract). New Zealand Society of Endocrinology Annual 
Scientific Meeting, Liggins Institute, Auckland. 
Prickett, T, Yandle, T, Nicholls, M, Espiner, EA, & Richards, A. (2001). Identification of 
amino-terminal pro-C-type natriuretic peptide in human plasma. Biochemical and 
Biophysical Research Communications, 286, 513-517. 
Prickett, TCR, Barrell, GK, Wellby, M, Yandle, TG, Richards, AM, & Espiner, EA. (2008b). 
Effect of sex steroids on plasma C-type natriuretic peptide forms: stimulation by 
oestradiol in lambs and adult sheep. Journal of Endocrinology, 199, 481-487. 
  
 107
Prickett, TCR, McNeill, BA, Oliver, MH, Harding, JE, & Espiner, EA. (2010a). Effect of 
cortisol on C-type natriuretic peptide (CNP) in ovine pregnancy: differential responses 
in fetal and placental tissues. Pediatric research, In press, doi: 
10.1203/PDR.1200b1013e3181f9039d. 
Prickett, TCR, McNeill, BA, Oliver, MH, Harding, JE, & Espiner, EA. (2010b). Increased 
fetal cortisol reduces fetal but not maternal plasma NTproCNP in late ovine gestation. 
Program of the 92nd annual meeting of the Endocrine Society, San Diego, CA. 
Prickett, TCR, Rumball, CWH, Buckley, AJ, Bloomfield, FH, Yandle, TG, Harding, JE, & 
Espiner, EA. (2007). C-type natriuretic peptide forms in the ovine fetal and maternal 
circulations: evidence for independent regulation and reciprocal response to 
undernutrition. Endocrinology, 148, 4015-4022. 
Prickett, TCR, Ryan, JF, Wellby, M, Barrell, GK, Yandle, TG, Richards, AM, & Espiner, EA. 
(2010c). Effect of nutrition on plasma C-type natriuretic peptide forms in adult sheep: 
evidence for enhanced C-type natriuretic peptide degradation during caloric 
restriction. Metabolism Clinical and Experimental, 59, 796-801. 
Redmer, DA, Luther, JS, Milne, JS, Aitken, RP, Johnson, ML, Borowicz, PP, Borowicz, MA, 
Reynolds, LP, & Wallace, JM. (2009). Fetoplacental growth and vascular 
development in overnourished adolescent sheep at day 50, 90 and 130 of gestation. 
Reproduction, 137, 749-757. 
Revell, DK, Morris, ST, Cottam, YH, Hanna, JE, Thomas, DG, Brown, S, & McCutcheon, 
SN. (2002). Shearing ewes at mid-pregnancy is associated with changes in fetal 
growth and develoment. Australian Journal of Agricultural Research, 53, 697-705. 
Reynolds, LP, Borowicz, PP, Caton, JS, Vonnahme, KA, Luther, JS, Hammer, CJ, Maddock 
Carlin, KR, Grazul-Bilska, AT, & Redmer, DA. (2010). Developmental programming: 
The concept, large animal models, and the key role of uteroplacental vascular 
development. Journal of Animal Science, 88, E61-E72. 
Reynolds, LP, Borowicz, PP, Vonnahme, KA, Johnson, M, Grazul-Bilska, AT, Redmer, DA, 
& Caton, JS. (2005a). Placental angiogenesis in sheep models of compromised 
pregnancy. Journal of Physiology, 565, 43-58. 
 108
Reynolds, LP, Borowicz, PP, Vonnahme, KA, Johnson, ML, Grazul-Bilska, AT, Wallace, 
JM, Caton, JS, & Redmer, DA. (2005b). Animal models of placental angiogenesis. 
Placenta, 26, 689-708. 
Reynolds, LP, & Redmer, DA. (1995). Utero-placental vascular development and placental 
function. Journal of Animal Science, 73, 1839-1851. 
Reynolds, LP, & Redmer, DA. (2001). Angiogenesis in the Placenta. Biology of 
Reproduction, 64, 1033-1040. 
Rhodes, L, Pearse, A, & Asher, G. (2003). Approaches in developing a successful trans-
cervical AI programme for farmed deer. Proceedings of the New Zealand Society of 
Animal Production, 63, 258-261. 
Rosenfeld, CR, Cox, BE, Roy, T, & Magness, RR. (1996). Nitric oxide contributes to 
estrogen-induced vasodilation of the ovine uterine circulation. Journal of Clinical 
Investigation, 98, 2158-2166. 
Samson, WK, Huang, FL, & Fulton, RJ. (1993). C-type natriuretic peptide mediates the 
hypothalamic actions of the natriuretic peptides to inhibit luteinizing hormone 
secretion. Endocrinology, 132, 504-509. 
Sanson, DW, West, TR, Tatman, WR, Riley, ML, Judkins, MB, & Moss, GE. (1993). 
Relationship of body composition of mature ewes with condition score and body 
weight. Journal of Animal Science, 71, 1112-1116. 
Schlumbohm, C, & Harmeyer, J. (2008). Twin-pregnancy increases susceptibility of ewes to 
hypoglycaemic stress and pregnancy toxaemia. Research in Veterinary Science, 84, 
286-299. 
Scotland, R, Ahluwalia, A, & Hobbs, A. (2005). C-type natriuretic peptide in vascular 
physiology and disease. Pharmacology and Therapeutics, 105, 85-93. 
Senger, PL. (2005). Pathways to pregnancy and parturition (2nd ed.). Pullman: Current 
conceptions. 
 109
Sharma, RK, Jenkinson, CM, Blair, HT, Kenyon, PR, & Parkinson, TJ. (2009). Maternal 
environment as a regulator of birth weight and body dimensions of newborn lambs. 
Proceedings of the New Zealand Society of Animal Production, 69, 10-14. 
Simon, A, Harrington, EO, Liu, GX, Koren, G, & Choudhary, G. (2009). Mechanism of C-
type natriuretic peptide-induced endothelial cell hyperpolarization. American Journal 
of Physiology, 296, L248-256. 
Spencer, TE, Burghardt, RC, Johnson, GA, & Bazer, FW. (2004). Conceptus signals for 
establishment and maintenance of pregnancy. Animal Reproduction Science, 82-83, 
537-550. 
Steegers, EAP. (1991). Atrial natriuretic peptide during human pregnancy and puerperium. 
Fetal and Maternal Medicine Review, 3, 185-196. 
Stepan, H, Faber, R, Stegemann, S, Schultheiss, HP, & Walther, W. (2002a). Expression of 
C-type natriuretic peptide in human placenta and myometrium in normal pregnancies 
and pregnancies complicated by intrauterine growth retardation. Fetal Diagnosis and 
Therapy, 17, 37-41. 
Stepan, H, Faber, R, & Walther, T. (2002b). Plasma levels and expression of C-type 
natriuretic peptide (CNP) in human placenta and myometrium in preeclampsia. 
Hypertension in Pregnancy, 21 (Supplement 1), 117. 
Stepan, H, Leitner, E, Bader, M, & Walther, T. (2000). Organ-specific mRNA distribution of 
C-type natriuretic peptide in neonatal and adult mice. Regulatory Peptides, 95, 81-85. 
Stepan, H, Leitner, E, Walter, K, Bader, M, Schultheiss, HP, Faber, R, & Walther, T. (2001). 
Gestational regulation of the gene expression of C-type natriuretic peptide in mouse 
reproductive and embryonic tissue. Regulatory Peptides, 102, 9-13. 
Stepan, H, Walther, T, Walther, D, & Faber, R. (1998). Detection of C-type natriuretic 
peptide in normal pregnancy. Journal of Perinatal Medicine, 26, 56-58. 
 110
Stingo, AJ, Clavell, AL, Heublein, DM, Wei, CM, Pittelkow, MR, & Burnett, JC, Jr. (1992). 
Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. 
American Journal of Physiology, 263, H1318-1321. 
Sudoh, T, Minamino, N, Kangawa, K, & Matsuo, H. (1990). C-type natriuretic peptide 
(CNP): a new member of natriuretic peptide family identified in porcine brain. 
Biochemical and Biophysical Research Communications, 168, 863-870. 
Suga, S, Itoh, H, Komatsu, Y, Ogawa, Y, Hama, N, Yoshimasa, T, & Nakao, K. (1993). 
Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular 
endothelial cells - evidence for CNP as a novel autocrine/paracrine regulator from 
endothelial cells. Endocrinology, 133, 3038-3041. 
Suga, S, Nakao, K, itoh, H, Komatsu, Y, Ogawa, Y, Hama, N, & Imura, H. (1992). 
Endothelial production of C-type natriuretic peptide and its marked augmentation by 
transforming growth factor-. Journal of Clinical Investigation, 90, 1145-1149. 
Symonds, M, Bryant, M, & Lomax, M. (1986). The effect of shearing on the energy 
metabolism of the pregnant ewe. British Journal of Nutrition, 56, 635-643. 
Symonds, ME, Bryant, MJ, & Lomax, MA. (1989). Lipid metabolism in shorn and unshorn 
pregnant sheep. British Journal of Nutrition, 62, 35-49. 
Takei, Y, Inoue, K, Ando, K, Ihara, T, Katafuchi, T, Kashiwagi, M, & Hirose, S. (2001). 
Enhanced expression and release of C-type natriuretic peptide in freshwater eels. 
American Journal of Physiology, 280, R1727-1735. 
Teixeira, CC, Agoston, H, & Beier, F. (2008). Nitric oxide, C-type natriuretic peptide and 
cGMP as regulators of endochondral ossification. Developmental Biology, 319, 171-
178. 
Togashi, K, Kameya, T, Kurosawa, T, Hasegawa, N, & Kawakami, M. (1992). 
Concentrations and molecular forms of C-type natriuretic peptide in brain and 
cerebrospinal fluid. Clinical Chemistry, 38, 2136-2139. 
 111
Tremblay, J, Desjardins, R, Hum, D, Gutkowska, J, & Hamet, P. (2002). Biochemistry and 
physiology of the natriuretic peptide receptor guanylyl cyclases. Molecular and 
Cellular Biochemistry, 230, 31-47. 
Vatnick, I, Schoknecht, P, Darrigrand, R, & Bell, A. (1991). Growth and metabolism of the 
placenta after unilateral fetectomy in twin pregnant ewes. Journal of Developmental 
Physiology, 15, 351-356. 
Vonnahme, K, Evoniuk, J, Johnson, M, Borowicz, P, Luther, J, Pant, D, Redmer, D, 
Reynolds, L, & Grazul-Bilska, A. (2008a). Placental vascularity and growth factor 
expression in singleton, twin, and triplet pregnancies in the sheep. Endocrine, 33, 53-
61. 
Vonnahme, KA, Arndt, WJ, Johnson, ML, Borowicz, PP, & Reynolds, LP. (2008b). Effect of 
morphology on placentome size, vascularity, and vasoreactivity in late pregnant sheep. 
Biology of Reproduction, 79, 976-982. 
Vonnahme, KA, Hess, BW, Nijland, MJ, Nathanielsz, PW, & Ford, SP. (2006). Placentomal 
differentiation may compensate for maternal nutrient restriction in ewes adapted to 
harsh range conditions. Journal of Animal Science, 84, 3451-3459. 
Vonnahme, KA, Wilson, ME, Li, Y, Rupnow, HL, Phernetton, TM, Ford, SP, & Magness, 
RR. (2005). Circulating levels of nitric oxide and vascular endothelial growth factor 
throughout ovine pregnancy. Journal of Physiology, 565, 101-109. 
Wallace, JM, Milne, JS, & Aitken, RP. (2005). The effect of overnourishing singleton-bearing 
adult ewes on nutrient partitioning to the gravid uterus. British Journal of Nutrition, 
94, 533-539. 
Walther, T, & Stepan, H. (2004). C-type natriuretic peptide in reproduction, pregnancy and 
fetal development. Journal of Endocrinology, 180, 17-22. 
  
 112
Walther, T, Stepan, H, Pankow, K, Gembardt, F, Faber, R, Schultheiss, H-P, & Siems, W-E. 
(2004). Relation of ANP and BNP to their N-terminal fragments in fetal circulation: 
evidence for enhanced neutral endopeptidase activity and resistance of BNP to neutral 
endopeptidase in the fetus. British Journal of Obstetrics and Gynaecology, 111, 452-
455. 
Wango, E, Wooding, FB, & Heap, R. (1990). The role of trophoblast binucleate cells in 
implantation in the goat: a morphological study. Journal of Anatomy, 171, 241-257. 
Ward, JW, Forhead, AJ, Wooding, FBP, & Fowden, AL. (2006). Functional significance and 
cortisol dependence of the gross morphology of ovine placentomes during late 
gestation. Biology of Reproduction, 74, 137-145. 
Ward, JW, Wooding, FBP, & Fowden, AL. (2002). The effects of cortisol on the binucleate 
cell population in the ovine placenta during late gestation. Placenta, 23, 451-458. 
Wathes, DC, Reynolds, TS, Robinson, RS, & Stevenson, KR. (1998). Role of the insulin-like 
growth factor system in uterine function and placental development in ruminants. 
Journal of Dairy Science, 81, 1778-1789. 
Wei, CM, Aarhus, LL, Miller, VM, & Burnett, JC, Jr. (1993). Action of C-type natriuretic 
peptide in isolated canine arteries and veins. American Journal of Physiology, 264, 
H71-73. 
Wheaton, JE, Carlson, KM, Windels, HF, & Johnston, LJ. (1993). CIDR: A new 
progesterone-releasing intravaginal device for induction of estrus and cycle control in 
sheep and goats. Animal Reproduction Science, 33, 127-141. 
Woodard, GE, & Rosado, JA. (2008). Natriuretic peptides in vascular physiology and 
pathology. International Review of Cell and Molecular Biology, 268, 59-93. 
Woodard, GE, Rosado, JA, & Brown, J. (2002). Expression and control of C-type natriuretic 
peptide in rat vascular smooth muscle cells. American Journal of Physiology, 282, 
R156-165. 
 113
Wooding, FB. (1982). The role of the binucleate cell in ruminant placental structure. Journal 
of Reproduction and Fertility, 31 (Supplement), 31-39. 
Wooding, FB. (1992). Current topic: the synepitheliochorial placenta of ruminants: binucleate 
cell fusions and hormone production. Placenta, 13, 101-113. 
Wooding, FB, & Burton, G. (2008). Comparative placentation: structures, functions and 
evolution. Berlin: Springer. 
Wooding, FB, Flint, AP, Heap, R, Morgan, G, Buttle, H, & Young, IR. (1986). Control of 
binucleate cell migration in the placenta of sheep and goats. Journal of Reproduction 
and Fertility, 76, 499-512. 
Wooding, FB, Morgan, G, Forsyth, IA, Butcher, G, Hutchings, A, Billingsley, SA, & 
Gluckman, PD. (1992). Light and electron microscopic studies of cellular localization 
of oPL with monoclonal and polyclonal antibodies. Journal of Histochemistry and 
Cytochemistry, 40, 1001-1009. 
Wooding, FB, Roberts, RM, & Green, JA. (2005). Light and electron microscope 
immunocytochemical studies of the distribution of pregnancy associated glycoproteins 
(PAGs) throughout pregnancy in the cow: possible functional implications. Placenta, 
26, 807-827. 
Wooding, FBP, Kimura, J, Fukuta, K, & Forhead, AJ. (2007). A light and electron 
microscopical study of the tragulid (mouse deer) placenta. Placenta, 28, 1039-1048. 
Wu, G, Bazer, FW, Wallace, JM, & Spencer, TE. (2006). Board-invited review. Intrauterine 
growth retardation: implications for the animal sciences. Journal of Animal Science, 
84, 2316-2337. 
Yamahara, K, Itoh, H, Chun, T-H, Ogawa, Y, Yamashita, J, Sawada, N, Fukunaga, Y, Sone, 
M, Yurugi-Kobayashi, T, Miyashita, K, Tsujimoto, H, Kook, H, Feil, R, Garbers, DL, 
Hofmann, F, & Nakao, K. (2003). Significance and therapeutic potential of the 
natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular 
regeneration. Proceedings of the National Academy of Sciences of the United States of 
America, 100, 3404-3409. 
 114
Yandle, TG. (1994). Biochemistry of natriuretic peptides. Journal of Internal Medicine, 235, 
561-576. 
Yandle, TG, Espiner, EA, Nicholls, MG, & Duff, H. (1986). Radioimmunoassay and 
characterization of atrial natriuretic peptide in human plasma. Journal of Clinical 
Endocrinology and Metabolism, 63, 72-79. 
Yandle, TG, Fisher, S, Charles, C, Espiner, EA, & Richards, AM. (1993). The ovine 
hypothalamus and pituitary have markedly different distributions of C-type natriuretic 
peptide forms. Peptides, 14, 713-716. 
Zhang, Z, Xiao, Z, & Diamond, SL. (1999). Shear stress induction of C-type natriuretic 
peptide (CNP) in endothelial cells is independent of NO autocrine signaling. Annals of 
Biomedical Engineering, 27, 419-426. 
Zhu, MJ, Du, M, Nijland, MJ, Nathanielsz, PW, Hess, BW, Moss, GE, & Ford, SP. (2009). 
Down-regulation of growth signaling pathways linked to a reduced cotyledonary 
vascularity in placentomes of over-nourished, obese pregnant ewes. Placenta, 30, 405-
410. 
 
 
 
